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PORPHYROMONAS GINGIVALIS INFECTION IN GESTATIONAL DIABETES 
MELLITUS AND SURVIVAL IN TOBACCO SMOKERS 
Himabindu Gogeneni 
July 28, 2017 
This thesis contains a clinical project and distinct basic science project. 
Gestational diabetes mellitus occurs in 4% of pregnancies and increases the risk of birth 
defects, pre-term birth, and miscarriage. Gingivitis during pregnancy also increases the 
risk for poor pregnancy outcome. Gingivitis is a bacterial-induced disease, and specific 
plaque pathogens have been associated with systemic sequelae to periodontal 
inflammation. Therefore, we set out to monitor oral infection with three key 
periodontopathogens (Porphyromonas gingivalis, Filifactor alocis, and Treponema 
denticola) and the systemic inflammatory burden [C-reactive protein (CRP)] in pregnant 
women with and without gingivitis and gestational diabetes. Gingivitis during pregnancy 
leads to a dramatic increase in systemic CRP (mean 8116 vs. 2495 ng/ml, p < 0.01), as 
determined by Enzyme Immunoassay (EIA). As expected, gingivitis during pregnancy was 
associated with oral infection with P. gingivalis, F. alocis and T. denticola and 
combinations thereof (all p < 0.01), as determined by salivary PCR. Gestational diabetes 
mellitus was also associated with increased infection with individual and multiple 
periodontopathogens, including P. gingivalis. Thus, diabetes and gingivitis act in concert 
to increase risk biomarkers for poor pregnancy outcome. Actual pregnancy outcomes in 
the study population are currently being monitored. 
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The majority of cases of chronic periodontitis in developed nations are tobacco-related. 
For periodontal pathogens, such as P. gingivalis, to induce or exacerbate periodontal 
diseases in smokers, they must first be able to survive the highly complex composite toxic 
insult represented by cigarette smoke. While it is clear that P. gingivalis is resistant to 
highdoses of cigarette smoke and tobacco constituents, the survival mechanisms are 
entirely unknown. Therefore, we first generated a P. gingivalis ATCC 33277 transposon 
sequencing (Tn-Seq, Library 1) and determined the putative minimal essential genome for 
in vitro growth in complex media in conjunction with a separate P. gingivalis ATCC 33277 
Tn-Seq library generated by Klein et al. (Library 2). In all, 281 genes (61%) identified by 
Library 1 were common to Library 2. Many of these common genes are involved in crucial 
metabolic pathways, notably pyrimidine cycling as well as lipopolysaccharide, 
peptidoglycan, pantothenate and coenzyme A biosynthesis, and nicotinate and 
nicotinamide metabolism. Also in common are genes encoding heat-shock protein 
homologs, sigma factors, enzymes with proteolytic activity, and the majority of Sec-related 
protein export genes. In addition to facilitating a better understanding of critical 
physiological processes, transposon-sequencing technology has the potential to identify 
novel strategies for the control of P. gingivalis infections. Those genes defined as essential 
by two independently generated TnSeq mutant libraries are likely to represent particularly 
attractive therapeutic targets.  
Next, we tested Library 1 for genes essential for the survival of exposure to cigarette 
smoke extract. Of the 2155 P. gingivalis ATTCC 33277 genes, 257 (8%) were found to be 
essential for growth upon cigarette smoke exposure. The essential genes were distributed 
throughout the bacterial genome. Genes with products that function in DNA metabolism, 
energy metabolism, signal transduction, protein fate and transport and binding proteins 
were best represented within the essential gene set. In a competition assay of the mutants 
vi 
 
of genes of biological interest, the following mutants were outcompeted by the wild type, 
P. gingivalis ATCC 33277 strain: PGN_1524 encoding uncharacterized protein, 
PGN_1474 (luxS) encoding S-ribosyl homocysteine lyase, PGN_1200 encoding putative 
ATPase,PGN_1444 (carA) encoding carbamoyl- phosphate synthase small chain,  
PGN_0770 (rnz) encoding ribonuclease Z, PGN_0714 encoding probable 
pyrazinamidase/ nicotinamidase, PGN_0491 encoding probable phosphotyrosine protein 
phosphatase , PGN_0287 (mfa1) encoding minor fimbrium subunit Mfa1 , PGN_0088 
encoding putative transcriptional regulator, and PGN_0388 (tpx) encoding putative thiol 
peroxidase. We confirmed the respective gene fitness in a Gifu anaerobic media 
conditioned with cigarette smoke extract (GAM-CSE) model. Further competition assays 
of the top 10 genes in the identified gene list, according to the fold change and 
complementation assays, could provide some of the first insights into how cigarette smoke 
changes the P. gingivalis phenotype in a manner likely to promote colonization and 
infection. Those genes identified as conditionally essential are likely to represent attractive 
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Next to dental caries, periodontal diseases are the most prevalent oral diseases in the 
world, affecting 10-15% of adult population, according to the WHO [1]. According to the 
CDC report, 47.2% of adults in the United States aged 30 years and older have some form 
of periodontal disease [2]. Periodontal diseases refers to inflammation of the periodontium, 
the supporting tissues of the tooth, and are the leading causes of tooth loss [3]. Clinically, 
periodontal diseases are characterized by gingival inflammation, gingival bleeding, and 
increased periodontal pocket depth [4]. According to the American Academy of 
Periodontology, periodontal diseases are broadly classified as gingivitis and periodontitis 
[5]. Gingivitis is the inflammation of gingiva without any bone loss, usually associated with 
the presence of bacteria.  Periodontitis is defined as inflammation of the gingiva extending 
into the adjacent attachment apparatus of the tooth [6]. Chronic periodontitis is the most 
prevalent form of periodontitis and has been associated with increased prevalence of 
diabetes mellitus, AIDS, leukemia, down’s syndrome, cardiovascular diseases, 
rheumatoid arthritis and pre-term low birth weight babies [7-11]. Chronic periodontitis is 
multifactorial, and its pathogenesis is characterized by the interaction of host (genetics), 
agent (oral biofilm), and environmental (patient behaviors like smoking, medications or 
systemic diseases) [3]. The pre-requisite for the development of the periodontal diseases 
is the presence of pathogenic biofilms [12]. 
1.1. Oral biofilm: 
Oral biofilm is defined by Costerton et al., as a structured community of bacterial cells 
enclosed in self-produced polymeric matrix and adherent to an inert or living surface. The 
first step in the oral biofilm formation process is the formation of the salivary pellicle, a thin 
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acellular film that forms on any surface upon exposure to saliva, providing a niche for the 
colonization of microorganisms through autogenic succession. Further oral bacteria 
secrete mucin, albumin, glycoproteins, acidic proline-rich proteins, etc. which form the 
matrix of the biofilm [13]. The microbes that colonize by adhering to salivary pellicle and 
initiate biofilm formation are primary colonizers. Primary colonizers are mainly 
commensals of the oral cavity such as Gram-positive bacilli and cocci including 
Streptococcus sanguis, Streptococcus oralis, Streptococcus mitis and Actinomyces 
viscosus. If left undisturbed, the primary colonizers promote the colonization of more 
pathogenic late colonizers such as Treponema denticola, Porphyromonas gingivalis and 
Tannerella forsythia [14, 15]. The biofilm is formed through a coordinated process, 
supporting a broad range of bacteria by providing a favorable niche for the periodontal 
pathogens [16]. The presence of certain species like P. gingivalis leads to dysbiosis, 
resulting in periodontal destruction [17]. However, the presence of biofilm alone is not 
sufficient to cause periodontal diseases [18]. Host immune response to these pathogens 
plays a crucial role in the periodontal tissue destruction. 
According to the polymicrobial synergy and dysbiosis (PSD) model, oral dysbiosis plays a 
crucial role in the pathogenesis of periodontal diseases. P. gingivalis, which is considered 
a keystone pathogen, alone failed to induce bone loss in germ-free mice but was able to 
induce bone loss when combined with other oral commensals [19]. P. gingivalis plays a 
crucial role in the pathogenesis of periodontitis by altering the oral biofilm composition and 
the host immune response to these altered biofilms [20, 21]. As per PSD model, 
periodontitis is believed to be initiated by synergistic and dysbiotic microbial communities 
[21]. Dysbiosis is characterized by the relative abundance of pathobionts, commensals of 
the biofilm that under certain conditions can cause pathology [22, 23], compared to 
commensals in the biofilm. The results of human clinical studies are in agreement with the 
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observations identified in animal models regarding the PSD model. Clinically, it has been 
shown that in the case of periodontal diseases, there is a decrease in the commensal 
organism Streptococcus sanguis [24, 25]. The results of transcriptional profiling of 
microbial samples from periodontally healthy versus diseased sites have demonstrated 
that the majority of potential virulence factors upregulated in human disease are derived 
from the bacteria associated with periodontal health [26]. Many recent studies, using 
Human Microbiome Project data set as a reference, have shown the difference in the 
biofilm structure and its functional capacities [27-30]. Studies involving recent 
advancements like 16S rRNA and shotgun sequencing have also confirmed the existence 
of significant differences in microbial communities between healthy and periodontal 
disease individuals [28-31]. This finding is further confirmed by the case-control study 
performed using Illumina Miseq Desktop Sequencing of subgingival samples [27, 32]. 
Cluster analysis by principal component analysis showed that the bacterial communities 
were different in healthy and periodontally diseased groups; Porphyromonas, Treponema, 
and Filifactor species were significantly enriched in the diseased group. Also, it has been 
shown that the chronic periodontitis sites contained greater microbial diversity and species 
richness compared to healthy control sites [27, 32]. 
In an oral biofilm, oral microorganisms interact through inter-microbial adhesion, cell 
signaling using cell-to-cell contact. Metabolic communications, including quorum sensing, 
also play a major role in maintaining the integrity of oral biofilm and an essential role in 
microorganism survival [33, 34], leading to coordinated gene expression within the 
microbial community that in turn influences the pathogen’s ability to cause disease [35, 
36]. Metatranscriptome analysis studies showed that there to be overexpression of 
biological functions related to flagellar motility, peptide transport, iron acquisition, beta-
lactam degradation and the biosynthesis of the lipid A component of endotoxins in the 
 4 
dental biofilms collected from active periodontal sites [26, 37]. Thus, in an individual with 
periodontitis, there is altered expression of genes related to particular physiological 
processes that help the microbes to survive in the changed environmental conditions of 
the dysbiotic biofilm . Further, these dysbiotic biofilms can lead to chronic inflammation by 
stimulating the host inflammatory response [21, 38]. 
In summary, periodontal diseases may be triggered by a conglomeration of several 
bacterial species, rather than a single pathogen, and be dependent on the microbial 
communities and their interactions. Dysbiosis of oral biofilms plays a crucial role in the 
pathogenesis of periodontal diseases by aggravating the host immune response to oral 
biofilms, leading to inflammation and bone loss [39]. Local environmental changes such 
as increased gingival inflammation, bleeding on probing, and increased periodontal pocket 
depth periodontal also alter bacterial gene expression related to survival fitness of the 
microbes in the biofilms. While most organisms in the subgingival microbiota are 
considered commensals, several bacteria have been implicated as periodontal pathogens 
including Porphyromonas, Treponema, and Filifactor. However, P. gingivalis and T. 
denticola were found in both healthy and periodontally diseased individuals.  In this study, 
we are interested in studying P. gingivalis, T. denticola, and F. alocis as they have shown 
a strong association with periodontal diseases. 
1.2. Treponema denticola: 
T. denticola is a Gram-negative bacterium from the Spirochetes family. It is motile, 
slender, helically-shaped, and flexible. It has been routinely isolated from human 
subgingival plaque and is strongly associated with changes in the subgingival ecology 
characteristic of disease sites [40-42]. T. denticola is considered as one of the main 
etiological agents for periodontitis [41, 43]. In contrast to the wide diversity of phylotypes 
in healthy sites, only a few phylotypes are found in diseased sites [44]. T. denticola can 
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lyse and damage periodontal cells, adhere to epithelial cells and fibroblasts, co-aggregate 
to biofilm-bridging organisms, and can produce proteins and polypeptides that interact 
with the host immune response [40]. In vitro studies have shown that components of T. 
denticola can induce a range of pro-inflammatory cytokines such as interleukin 1(IL-1), 
tumor necrosis factor (TNF), IL-6 and IL-8 [45]. It has been found that the proportion of T. 
denticola increases significantly in periodontal disease biofilms. T. denticola  is typically 
detected together with other pathogens P. gingivalis and T. forsythia [46]. In murine 
models of periodontitis, synergy between organisms has been demonstrated by 
inoculation of animals with P. gingivalis together with either T. denticola or T. forsythia, 
resulting in more extensive alveolar bone destruction than inoculation with a single species 
[47, 48]. Thus, the prevalence of T. denticola in periodontal pockets, together with high 
numbers of other proteolytic Gram-negative bacteria, may play a major role in the 
progression of periodontal disease. One of the challenges of researching treponemes, 
such as T. denticola, is the difficulty of their cultivation in vitro. T. denticola requires the 
presence of fibronectin coating to facilitate its attachment, and it is difficult to obtain a 
model system for biofilm growth for pure cultures of T. denticola [49]. Hence little work has 
been done on T. denticola biofilm growth.  
1.3. Filifactor alocis:  
Recent advances in sequencing techniques have allowed the identification of 
microorganisms within the subgingival dental biofilm, which had previously been 
unrecognized because of culture difficulties. F. alocis has been identified as potential 
pathogen in recent non-culture based studies [27, 50]. F. alocis is a fastidious, Gram-
positive, obligately anaerobic rod. It is considered to be an important pathogen in the 
formation of subgingival biofilm and the onset of periodontal diseases [31]. Owing to its 
high prevalence and abundance in periodontal disease sites compared with healthy sites, 
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it is considered as a potential marker for active disease [27, 51, 52]. F. alocis is relatively 
resistant to oxidative stress and possesses several virulence factors, such as 
sialoglycoproteins, proteases, adhesion molecules, neutrophil-activating protein A, and a 
calcium-binding acid repeat protein [31]. F. alocis can stimulate the production of host pro-
inflammatory cytokines IL-1β, IL-6, and TNF, which in turn can stimulate pathways that 
activate osteoclasts and increase alveolar bone resorption [53, 54]. F. alocis can also 
interact with other oral bacteria and form biofilms [55]. F. alocis has also been shown to 
enhance the virulence or the growth of other pathogens, promoting the pathogenesis of 
periodontitis [31]. For example, F. alocis synergistically interacts with P. gingivalis [56], 
enhancing biofilm formation and invasion of epithelial cells by when in coculture. F. alocis 
also interacts synergistically with F. nucleatum in vitro [57]. It was previously shown that 
F. alocis is involved in numerous spatial arrangements with other organisms, indicating its 
role as one of the architects of structural organization within periodontal biofilms [55].  
1.4. Porphyromonas gingivalis: 
P. gingivalis is a Gram-negative, black-pigmented, obligately anaerobic organism, and the 
most studied of the periodontal pathogens. This species was found in 85.75% of 
subgingival plaque samples from patients with chronic periodontitis [58]. Colonization 
by P. gingivalis is also associated with some systemic diseases, including cardiovascular 
diseases, rheumatoid arthritis, and Alzheimer's disease [59-61]. Its occurrence is higher 
in subjects with chronic periodontitis compared to periodontally healthy subjects [62, 63].  
P. gingivalis is considered to be a keystone pathogen in the pathogenesis of periodontitis, 
due to its disproportionate influence on the microbiome in relation to its abundance [17, 
64]. P. gingivalis was identified as a keystone pathogen in a study using a combination of 
culture-based methods and next-generation sequencing( NGS) [65]. Human studies have 
also shown that P. gingivalis is present in low abundance when compared with the total 
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oral microbiota in disease sites [52]. P. gingivalis benefits from a variety of interactions 
with other bacteria under deprived oxygen conditions. Studies have also demonstrated 
that P. gingivalis can be present in the subgingival biofilm and colonize the epithelium in 
healthy individuals [66, 67]. In vivo studies have shown that even though P. gingivalis is 
present in low numbers, its presence enhances the growth of pathogenic microflora which 
in turn leads to periodontal diseases [19]. On its own, P. gingivalis does not induce disease 
in germ-free mice, yet it can shift the balance of microflora in oral cavity towards a more 
pathogenic community, resulting in periodontal diseases. Thus pathogenicity of P. 
gingivalis is related not only to its physiological state but also to its interactions with other 
oral microflora [22].  
The means by which early colonizers facilitate colonization by P. gingivalis include the 
provision of attachment sites for adherence, the supply of growth substrates, and 
reduction of oxygen tension to the low levels required for growth and survival [68]. P. 
gingivalis can adhere to both early and late colonizers of oral biofilm. P. gingivalis plays a 
crucial role in the autogenic succession of oral microflora towards more Gram-negative 
bacteria leading to dysbiosis [28, 62, 69]. In a mouse model, it has been shown that, 
despite low numbers, P. gingivalis created dysbiotic changes in the oral biofilm. Further, 
it has been shown that dysbiosis can be triggered by keystone pathogens such as P. 
gingivalis and is characterized by an increase in the prevalence of pathobionts [24, 25, 
70]. A recent study also proved the concept of keystone pathogen-mediated (P. gingivalis) 
PSD model to explain the etiology of periodontitis [71].  
In vitro studies revealed that P. gingivalis produces a wide array of putative virulence 
factors including fimbriae, capsules, lipopolysaccharide (LPS), lipoteichoic acids, 
hemagglutinins, gingipains (secreted proteases), outer membrane proteins, and outer 
membrane vesicles [72, 73]. However, the mere presence of virulence factors itself is not 
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sufficient to induce attachment and bone loss. Host immune response to these virulence 
factors, and to the bacteria as a whole, plays a crucial role in the pathogenesis of 
periodontitis [74, 75]. The virulence factors of P. gingivalis are known to suppress the host 
immune response, thus promoting the growth of commensals in the oral biofilm [39]. In 
vitro studies have shown that P. gingivalis can induce proinflammatory cytokines such as 
IL-1α, IL-1β, TNF, IL-6, and IL-8 [76, 77]. A study by Guentsch et al., showed that 
extracellular release of reactive oxygen species (ROS) by neutrophils occurred when 
exposed to P. gingivalis.  This phenomenon may lead to destruction of the bacteria and 
damage to the surrounding periodontal tissue. P. gingivalis can also upregulate the 
collagen-degrading ability of some human gingival fibroblast (HGF) cell lines [78], thus 
may have a role in enhancing periodontal tissue degradation in vivo. 
1.5. P. gingivalis virulence factors: 
Fimbriae  
The fimbriae of P. gingivalis are thin, filamentous, cell surface protrusions. Two classes of 
fimbriae exist, Type I (major) fimbriae and type II (minor) fimbriae. Type I (major) fimbriae 
have significant roles in colonization and invasion, whereas type II (minor) fimbriae 
possess a higher pro-inflammatory capacity [79-81]. Fimbrillin, a protein in the major 
fimbriae, is encoded by fimA gene. This gene was classified into six genotypes according 
to its genomic differences [82, 83]. fimA type I was associated with periodontal health. 
Genotype II has greater adhesive and invasive properties, has been observed to be more 
prevalent in periodontal patients, and is associated with more aggressive forms of 
periodontal disease. In mouse models, type I and III induced weak inflammation whereas 
type II, Ib, IV, and V induced strong inflammation [84]. In experimental periodontitis 
models, fimbriae induced bone destruction. In rat models, infection with non-
fimbriated P. gingivalis strains exhibited reduced periodontal bone loss, compared with 
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infection with fimbriated strains [85]. Immunization against P. gingivalis fimbriae protected 
against bone loss in gnotobiotic rats [86]. Other properties of both major and minor 
fimbriae include the induction of pro-inflammatory cytokines and production of matrix 
metalloproteinases (MMPs), such as IL-1, IL-6, IL-8, TNF, and MMP-9, by various host 
cells [87-89]. P. gingivalis fimbriae can signal through either TLR2 or TLR4. Activation of 
TLR2 by fimbriae results in a distinctive signaling pattern compared with activation 
by P. gingivalis LPS [90]. The differential signaling pattern, in turn, activates the binding 
capacity of CR3 and allows for internalization of P. gingivalis in macrophages and 
reduction of IL-12 production, which may collectively inhibit bacterial clearance [91].  
Proteases 
Proteases were classified as serine, cysteine, and metalloproteinase depending on the 
catalytic mechanisms. These include gingipains (Arg- or Lys-), periodontain (cysteine 
endopeptidase), PrtT proteinase, Tpr proteinase, collagenase (prtC gene), prolyl 
tripeptidyl peptidase (serine exopeptidase), dipeptidyl-peptidase IV (serine exopeptidase 
known as glycylprolyl peptidase, a product of the dppIV gene), dipeptidyl-peptidase VI 
(putative cysteine exopeptidase), amino-peptidase P, oligo-peptidase O and gelatinase (a 
proteinase degrading type IV collagen, gelatin, low-molecular-mass-kininogen and 
transferrin) [92]. Of these, the collagenases, aminopeptidases, and the trypsin-like 
proteases are critical to P. gingivalis pathogenesis [72].  
P. gingivalis, an asaccharolytic organism, expresses a set of trypsin-like proteases that 
degrade proteins to use as an energy source, for processing of P. gingivalis proteins such 
as fimbriae and also potentiates inflammation [93, 94]. Gingipains are cysteine proteases 
that can cleave the proteins at arginine and lysine specific sites [95]. A variation on the 
genotype level of the proteolytic enzymes (gingipains) has been reported [96, 97]. P. 
gingivalis produces Lys-X and Arg-X peptide bonds specific proteases (Kgp, RgpA, and 
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RgpB gingipains) which are considered as a major virulence determinant. The activation 
of inflammation is part of a basic survival strategy, increasing the protein-rich gingival 
crevicular fluid bathing the gingival sulcus while dampening killing mechanisms in 
phagocytic cells [98]. Three types (type A, B, and C) of the Arg-specific cysteine 
proteinase-encoding genes (prpR1/rgpA) and two (type I and II) of the Lys-specific 
cysteine proteinase-encoding genes (kgp) were identified in these studies. These 
gingipains can up-regulate MMP-8 and MMP-3 expression in rat mucosal epithelial cells 
and activate latent MMPs [99, 100]. MMPs activation may, in turn, induce connective 
tissue and bone destruction leading to periodontitis [74]. Gingipains also deregulate the 
various components of the immune response [101] which, in turn, hampers bacterial 
clearance and facilitates bacterial invasion.  
Capsule 
The capsule is another important virulence factor of P. gingivalis [102, 103]. Six different 
serotypes of capsules have been identified depending on capsular polysaccharide K-
antigens and their capacity to generate systemic IgG antibodies [104]. Bacterial 
encapsulation is positively correlated with increased resistance to phagocytosis [105]. In 
comparison to non-encapsulated strains, encapsulated P. gingivalis strains are shown to 
be highly invasive, causing spreading infection in a murine lesion model and more 
resistance to phagocytosis by PMN [106, 107]. P. gingivalis capsule polysaccharide 
(CPS) mutant strain was found to be a more potent inducer of cytokine synthesis by human 
gingival fibroblasts compared with the corresponding wild-type strain. Thus CPS hampers 
the innate immune response [102, 103]. In an animal model, immunization with P. 





LPS is a cell wall component of Gram-negative bacteria and is composed of O-antigen, 
core polysaccharide and lipid A. Lipid A exists predominantly in two forms in P. gingivalis 
- the tetra-acylated and penta-acylated forms. The penta-acylated lipid A activates TLR4, 
whereas tetra-acylated lipid A acts as a TLR4 antagonist [109, 110].  P. gingivalis LPS is 
thus a weaker cytokine stimulator compared with that of other Gram-negative bacteria. In 
vitro, it stimulates the production of pro-inflammatory cytokines such as IL-1α, IL-1β, IL-6, 
IL-8, IL-18 and TNF in monocytes [75, 111-113]. In animal models, it has been shown that 
P. gingivalis LPS triggers pro-inflammatory responses and bone resorption in the oral 
cavity [114]. In summary, P. gingivalis LPS leads to host immunological deregulation, thus 
facilitating the P. gingivalis adaptation and survival.  
Recent studies showed that the expression of virulence factors of P. gingivalis is regulated 
in response to environmental changes. To ensure optimal nutrient uptake in response to 
environmental changes, P. gingivalis adopts various methods to utilize iron and heme 
[115]. It was found that fimA gene expression was decreased by approximately 50% in 
response to hemin limitation and the presence of serum or saliva in the growth medium 
[116]. Environmental conditions influence the changes in P. gingivalis lipid A acylation. 
Penta-acylated lipid A is converted into tetra-acylated lipid A when there is inflammation 
(high hemin availability), thus modulating host immune response [117]. Thus, P. gingivalis 
adapts to the environmental changes in the oral cavity for its survival within the host. 
1.6. Host influence on P. gingivalis 
Clinically periodontal diseases are characterized by gingival inflammation, bleeding on 
probing and increased pocket depth. Apart from the host immune response, bacterial 
adaptation to these local host environmental changes also plays a significant role in 
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survival and towards the pathogenesis of periodontal diseases [118]. It has been shown 
in many studies that P. gingivalis can alter expression of several genes in response to 
varied environmental conditions as a part of its survival strategy. 
In response to a change in pH or temperature, P. gingivalis alters the biophysical 
properties of its membrane lipids [22].  Despite being anaerobe, P. gingivalis is micro-
aerotolerant. It has been shown that on exposure to oxygen, P. gingivalis adapts to the 
aerobic conditions through upregulation of genes encoding adhesins and phosphatases, 
and the downregulation of protease-encoding genes and proteins interfering with 
adhesion [119]. On exposure to atmospheric oxygen, there is upregulation of genes 
involved in oxidative stress, and in virulence factors involved in heme acquisition, 
presumably as a protective mechanism against the molecular oxygen and the reactive 
oxygen species [120]. Heme is an essential nutrient for P. gingivalis survival. In a 
combined quantitative proteomic and transcriptomic analysis study, it has been shown 
that P. gingivalis upregulates the production of several proteins linked to metabolism, 
oxidative stress response, virulence, and invasion of host cells to cope  with heme 
limitation [121]. In vivo studies have shown that the expression of virulence factors in P. 
gingivalis increase after hemin limitation [121, 122]. The heme-binding lipoprotein HmuY, 
GAPDH and some of the cell-surface-located C-terminal domain (CTD) family proteins, 
including RgpA, HagA, CPG70, and PG99, are increased in biofilm cells. Concurrently, 
the heme-binding protein IhtB, TonB-dependent receptor P92, Kgp, lipoprotein RagB, 
endopeptidase PepO, a glutamine cyclotransferase-related protein, fumarate reductases 
FrdAB, and ribosomal proteins L10, L13 and L25 are significantly decreased. There is a 
differential response of P. gingivalis to varying concentrations and durations of hydrogen 
peroxide [123]. As a response to shorter exposure to H2O2-induced oxidative stress, genes 
involved in DNA replication, recombination and repair were upregulated [123, 124]. After 
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a longer exposure, several genes involved in protein folding/repair were upregulated 
whereas those involved in translation were downregulated. Thus, P. gingivalis is capable 
of sensing and rapidly responding to changes in its environment. 
1.7. P. gingivalis strains: 
Different clones of P. gingivalis in subgingival plaque samples have been found [125, 126]. 
In “Java Project on Periodontal Disease”, a longitudinal study performed over a span of 8 
years to investigate the clonal stability of P. gingivalis [127], 24 P. gingivalis genotypes 
were detected that occurred in one subject only. This heterogenicity among P. gingivalis 
strains might arise due to mobile genetic elements such as many insertional sequences 
(IS) and transposons; pathogenic islands like the rag locus [128-130]. Genetic variation 
also arises as a consequence of conjugal transfer leading to allelic exchange in P. 
gingivalis [131-133]. 
The rag locus, a novel pathogenicity island, encodes RagA and RagB, entities that 
constitute a membrane transport system. RagA is an 115-kDa TonB-dependent outer 
membrane receptor, and RagB is a 55-kDa lipoprotein constituting an immunodominant 
outer antigen [134]. Several studies suggested the virulence of rag locus. In a study 
conducted in Columbia, 32 P. gingivalis isolates were analyzed and shown to contain a 
greater bacterial diversity due to the rag locus. Four rag locus P. gingivalis variants differ 
in their pathogenicity [134-136]. P. gingivalis carrying rag-1, rag-3 was more predominant 
in chronic periodontitis patients in Northeast China [137]. P. gingivalis- rag locus gene 
mutants show reduced virulence in a mouse model study [138].  
P. gingivalis strains are classified as invasive or non-invasive strains based on differences 
in the ability to cause soft-tissue abscesses following subcutaneous injections at distant 
or local sites [139]. Different strains were also identified depending on their capacity to 
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cause periodontal bone loss, serum and saliva antibody expression and death in mice 
[140-142]. A difference in both alveolar bone resorption and the systemic acquired 
immune response was also found among different strains of P. gingivalis [143, 144]. 
In summary, several strains of P. gingivalis have been identified.  Chronic periodontitis is 
not associated with a particularly virulent clonal type [145]. ATCC 33277 is one of the most 
commonly employed strains in periodontal research. It is pathogenic in experimental 
animals following oral infection [146]. Thus, we used P. gingivalis ATCC 33277 strain in 
our study in chapter 3. 
1.8. P. gingivalis ATCC 33277 genome:  
Naito et al. presented the whole genome sequence of P. gingivalis ATCC 33277[147]. The 
genome of ATCC 33277 comprised a single circular chromosome of 2,354,886 bp with an 
average G + C content of 48.4% [147]. The ATCC 33277 genome contained 2155 genes, 
2090 protein coding sequences (CDSs) with a mean size of 970 bp, covering 86.1% of 
the whole chromosome sequence, approximately 117,000 TA sites, and no plasmids [32, 
147, 148]. It contains 4 RNA operons and 53 tRNA genes that provide specificity for amino 
acids. ATCC 33277 contained a variety of mobile genetic elements [147]. Only four NCBI 
annotated genes coding hypothetical proteins lack TA sites [148]. A total of 93 insertion 
sequence elements and 48 miniature inverted-repeat transposable elements were found 
in ATCC 33277. Insertion sequences are the simplest transposable elements, encoding a 
transposase and can be as short as 600–700 bp. The insertion sequence elements 
identified in ATCC 33277 were classified into six types, ISPg1–ISPg6, all of which are also 
present in W83 [149].  
Apart from ATCC 33277, the complete genome sequence of the strains W83, HG66, 
TDC60, and JCVISC001 are known. Three copies of 16S rRNA sequences in HG66 are 
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identical to the four copies of 16S rRNA sequences in ATCC 33277, suggesting a close 
evolutionary lineage between HG66 and ATCC 33277. Genome-wide comparisons based 
on Rapid Annotation using Subsystem Technology (RAST) also showed that for the 
overall biological functions of the genomes, ATCC 33277 is closer to HG66 compared to 
other strains. By comparing genome sequences of ATCC 33277 and W83 strains, 461 
ATCC 33277-specific and 415 W83-specific predicted protein coding sequences were 
identified. Between the two strains, 175 regions with genomic rearrangements were 
observed. These rearrangements occurred as a result of various mobile genetic elements 
such as insertion sequences, miniature inverted-repeat transposable elements, 
transposons, and conjugative transposons (CTns) [147]. 
In summary, the expression of virulence factors by the periodontal pathogen is often 
regulated in response to changes in the external environment. In the subgingival area, 
bacteria experience dramatic environmental changes resulting from host eating and oral 
hygiene patterns, gingival crevicular flow rate variability, and the degree of bleeding. In 
response to these dynamic processes, bacteria often regulate gene expression to 
maintain optimal phenotypic properties. Many studies have shown that each virulence 
factor plays important roles to hamper the cell-mediated immune response in the host. 
However, in the host, the bacteria express a whole subset of virulence factors rather than 
any single virulence factor. Thus, analysis of the bacterial genome is crucial to understand 
the properties and role of virulence factors as a whole. In chapter 2, the generation of a P. 
gingivalis ATCC 33277 transposon mutant library is described. We compared the 
generated library with the TnSeq library generated by Klein et al., to identify the common 
inherently essential genes in P. gingivalis ATCC 332777 strain. Further, the generated 
mutant library can be tested under various experimental conditions to investigate the 
conditional genes essential for P. gingivalis survival in those conditions. 
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In a susceptible host, dysbiosis can trigger abnormal host responses leading to the 
destruction of periodontal tissues and periodontal diseases [6, 150, 151]. The host-
bacterial interactions are estimated to account for almost 80% of the risk of periodontal 
tissue damage [152]. A potentially virulent microbe remains avirulent in an insusceptible 
host. Thus, the presence of variable complex microbial patterns in a susceptible host and 
the inflammatory immune response plays a significant role in the outcome of periodontal 
diseases. The result of this interaction is, in turn, dependent on many other risk factors 
including smoking, systemic conditions such as gestational diabetes mellitus (GDM), and 
other factors including age, gender, and socioeconomic status.  
1.9. Periodontal diseases and tobacco smoking:  
Cigarette smoking is strongly associated with multiple diseases, including lung cancer, 
chronic obstructive pulmonary disease, heart disease, respiratory infection, and 
periodontitis [153-156]. It is considered to be the single major preventable environmental 
risk factor for chronic periodontitis through its influence on the microbial composition of 
the biofilm [28, 62, 157, 158] and the host immune system [155]. 
Smoking-related periodontitis is a significant global public issue, as there are >1 billion 
adult smokers worldwide. Approximately half of the periodontitis cases in the U.S.A. could 
be attributable to smoking, and current smokers were about four times more likely to be 
diagnosed with periodontitis than never smokers [159]. Smokers are refractory to 
periodontal treatment compared to non-smokers [160]. Cross-sectional studies have 
shown that smokers are two to seven times more likely to present with periodontitis, 
compared to non-smokers [159, 161]. Clinical studies have demonstrated that smokers 
have the more severe periodontal disease [162-164]. A recent country wide 
epidemiological study conducted in Sweden suggested a strong association between 
smoking and moderate and severe alveolar bone loss overall [165]. In a cohort study 
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carried out in New Zealand, it has been found that the extent and prevalence of alveolar 
bone loss was greater in smokers compared to never smokers and former smokers [166]. 
In a large population-based prospective cohort study of men and women in the state of 
Brandenburg, Germany, a strong dose-dependent association between cigarette smoking 
and the prevalence and incidence of tooth loss has been found. This association is 
independent of other risk factors and potential confounders [167]. In studies, conducted 
using cloning and sequencing methods, smokers are associated with higher prevalence 
of periodontal pathogens compared to non-smokers [168]. In a Dunedin birth cohort study, 
investigators followed up people born in 1973. They confirmed the strong association 
between chronic smoking and periodontal disease [169]. 
Tobacco smoke contains over 7000 different chemicals, including carbon monoxide, 
hydrogen cyanide, reactive oxidizing radical.  Sixty of these chemicals are known or 
suspected  carcinogens [170] and the most abundant alkaloid is nicotine . Tobacco smoke 
contains carbon monoxide which will lower the oxygen saturation of hemoglobin in healthy 
gingiva resulting in a significant reduction of oxygen tension within the periodontal pockets 
in smokers [171]. This decrease in oxygen tension may favor the growth of anaerobic 
bacteria, even in the shallower pockets. Periodontitis is caused by over-expression of pro-
inflammatory cytokines and inflammatory mediators at the periodontium. In smoking-
associated periodontitis, bone loss occurs because of various osteolytic mediators such 
as IL-1β, IL-8, RANKL, MMP-2, MMP-9, and tPA. 
1.9.a. Smoking and the host immune response to oral microorganisms: 
The susceptibility of epithelial cells, the mechanical protective barriers of the tissue, to 
become colonized by periodontal pathogens is modulated by smoking [172]. In an in vitro 
study, it has been shown that cigarette smoke could impair epithelial innate immune 
responses to microbial products, allowing overgrowth and invasion [173]. Nicotine can 
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suppress osteoblast proliferation while stimulating alkaline phosphatase activity, 
enhancing the bone loss. The ability of tobacco products to decrease the proliferative 
capacity of T and B lymphocytes might contribute to this diminished production of 
protective antibodies [174]. Nicotine induces pathological changes in human periodontal 
tissue, resulting in altered morphology and structure of host cells, decreased bone volume, 
and tooth loss [163, 175-177]. Cigarette smoke also reduces the host response to 
periodontopathic bacteria, resulting in a more destructive periodontitis [178]. Numerous 
functions of oral or peripheral neutrophils are negatively affected by smoking or nicotine 
exposure, including phagocytosis, superoxide, and hydrogen peroxide generation, integrin 
expression, and protease inhibitor production [179]. Because of down-regulation of anti-
inflammatory factors along with an upregulation of pro-inflammatory cytokines, there might 
be increased infection risk by periodontal pathogens in smokers. Smokers are susceptible 
to colonization by P. gingivalis, a causative agent of periodontitis [180]. 
1.9.b. Smoking and oral microflora: 
There are conflicting reports on the effects of smoking on oral microflora with some studies 
reporting no differences between smokers and non-smokers in the detection of periodontal 
pathogens [181, 182]. Some reported that smoking has little effect on the subgingival 
microflora [183-187].  
At the same time, studies have suggested that smokers harbor a greater number of 
periodontal pathogens than non-smokers [188-191]. Recent studies, using real-time PCR, 
have demonstrated a positive relationship between the degree of smoking and amount of 
bacteria and probing depth [192, 193]. In these investigations, the subgingival microbiome 
of smokers was examined by traditional methods such as culturing, and targeted DNA-
based assays such as polymerase chain reaction (PCR), real-time PCR, and DNA–DNA 
hybridization.  
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Owing differences in the experimental design and interpretation of the results, there might 
be variations in the results. Microbiological studies showed that smokers had a higher 
prevalence of bacterial species related to periodontal disease compared to nonsmokers, 
including P. gingivalis, Aggregatibacter actinomycetencomitans, Bacteroides forsythus, 
Prevotella intermedia, and Fusobacterium nucleatum. Data from the large Erie County 
study showed that the proportions of subjects positive for Aggregatibacter 
actinomycetamcomitans [194], P. gingivalis, and Tannerella forsythia [195] were higher 
among smokers. The oral biofilm in smokers is distinct from that of nonsmokers by less 
diversity [62].The flora of smokers contains fewer aerobic and anaerobic organisms with 
interfering activity against bacterial pathogens, and harbors more potential pathogens. 
Smoking cessation can lead to a decrease in the prevalence or proportion of many 
periodontal pathogens, including Porphyromonas endodontalis, Dialister pneumosintes, 
Parvimonas micra, F. alocis and T. denticola [196]. Increased prevalence of the keystone 
pathogen P. gingivalis, has repeatedly been shown and infection is more persistent in 
smokers compared with non-smokers [197]. The adoption of 16S ribosomal RNA gene 
(rDNA) amplification by PCR, followed by cloning and sequencing, has allowed more 
comprehensive broad-range investigation of oral bacterial communities. This method 
allowed for the identification of many un-culturable unknown species in subgingival biofilm 
[198, 199]. These studies identified that the microbial profile of smokers with periodontitis 
is distinct from that of non-smokers and predominated by periodontal pathogens [158, 
198, 200]. 
1.9.c. Cigarette smoke and P. gingivalis: 
It is assumed that the oral cavities of smokers, including the oral tissues and their 
microbiota, are exposed to high concentrations of nicotine and cotinine [201]. Nicotine and 
cotinine concentrations are much higher in saliva and gingival crevicular fluid than in 
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plasma [202]. Nicotine is the abundant alkaloid and cotinine is the primary metabolite of 
nicotine. In vitro and in vivo studies have demonstrated that nicotine can affect various 
functions of human periodontal ligament fibroblasts, upregulate the lipopolysaccharide-
mediated secretion of prostaglandin E2 by monocytes, stimulate osteoclast resorption, 
augment cytokine levels in nicotine-treated mice and have other deleterious effects on the 
periodontal tissues [203-208]. Sayers et al. reported a synergic interaction 
between P. gingivalis toxins and nicotine or cotinine. The colonization of epithelial cells 
by P. gingivalis may also be altered in the presence of nicotine or cotinine [172, 209]. 
Nicotine and cotinine, have been shown to increase the lethality of cell-free extracellular 
toxins and cell lysates from P. gingivalis in a chick embryo model [210, 211]. The 
combination of benzopyrene, a tobacco smoke aryl hydrocarbon, and P. 
gingivalis lipopolysaccharide (LPS) significantly increase the inhibition of osteogenesis in 
a rat bone marrow cell model compared to either agonist alone [212]. In an in vitro model, 
periodontal ligament (PDL) cells treated with both nicotine and LPS increased the 
expression of MMP-1, MMP-2, MMP-3, PGE2, cyclooxygenase-2 (COX-2) and tissue-type 
plasminogen activators in osteoblasts [213, 214]. It also stimulates the formation of 
osteoclast-like cells by increasing macrophage colony-stimulating factor and 
PGE2 production in osteoblasts [215]. Nicotine and LPS synergistically induced the 
production of nitric oxide and PGE2, and increased the expression of inducible nitric oxide 
synthase (iNOS) and COX-2 via heme oxygenase-1 in PDLCs [216]. From these studies, 
it is evident that the pro-inflammatory potential of P. gingivalis is reduced in the presence 
of nicotine. This synergy, between nicotine and P. gingivalis LPS, results in deregulation 
of several host immune responses which work to combat the invading bacteria, thus 
promoting the growth of other pathogenic bacteria. 
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Other studies explain the increased infection in smokers due to modification of host 
immunity, but few studies explain the influence of tobacco smoke on the agent factors 
(oral bacteria). Host and environmental stimuli may confer a selective growth advantage 
to pathogenic organisms. Bacterial adaptation to these environmental conditions might be 
the cause for the persistent bacterial infection in smokers [69]. 
Virulence of periodontal pathogens may vary as a result of differed gene expression of 
virulence factors specific to particular environmental conditions [69, 217]. In a study done 
by Bagaitkar et al., it was shown that CSE (cigarette smoke extract) significantly influences 
the expression of 6.8% of the P. gingivalis genome, as determined by microarray analysis. 
This included genes regulating capsule and fimbriae, oxidative stress and, DNA repair. 
Regulation in response to CSE of fimA and capsule was further confirmed by an in vitro 
study, where there was a significant increase in homotypic biofilm formation in the 
presence of CSE [218]. 
P. gingivalis adapts to the environmental stress induced by CSE by altering the expression 
of several genes and outer membrane proteins [180]. To withstand these adverse effects, 
there might be upregulation of certain genes for the repair of damaged organelles. Despite 
information regarding various virulence factors of P. gingivalis and their host interactions 
at the phenotypic level, the genes essential for the survival of P. gigngivalis in smokers 
have not been identified.  
1.10. Periodontal diseases and GDM: 
Pregnancy is associated with the development of new periodontal disease and 
progression of periodontitis [219, 220]. The prevalence of gingivitis in pregnant women 
has reportedly ranged from 30% to 100% [220]. Globally, 40% to 60% of females 
experience gingivitis during their pregnancy [221]. The severity of pregnancy-related 
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gingivitis usually increases in the second trimester. Periodontal diseases are associated 
with pre-term labor and congenital disabilities [222]. GDM also has been associated with 
poor pregnancy outcomes including preeclampsia, cesarean delivery, premature rupture 
of membranes, and preterm delivery [223-226]. GDM is defined as any degree of glucose 
intolerance with an onset first recognized during pregnancy [227]. As per a Center for 
Disease Control and Prevention (CDC) report, the prevalence of GDM in the United States 
may be as high as 9.2%. The International Diabetes Federation (IDF), Diabetes Atlas 
2015, estimates that one in seven births is affected by GDM. Women with gestational 
diabetes had a greater risk of developing more severe periodontal disease during 
pregnancy than those without [228, 229]. It has been shown that poor glycemic control 
results in increased subgingival infection with P. gingivalis and T. denticola [230]. Studies 
have indicated that treating periodontal disease in pregnancy can reduce the likelihood of 
pre-term birth.  Others have found no such reduction for births at less than 37 weeks of 
gestation, but have suggested evidence of a benefit for births before 32 weeks [231-234].  
Inflammatory mediators that occur in periodontal disease play a significant role in the 
initiation of labor [235]. Increased levels of C-reactive protein, TNF-α, and IL-6 among 
women with gestational diabetes mellitus suggest a role of infection and inflammation in 
its etiology [236-238]. In a study by Dasanayake et al., women with gestational diabetes 
mellitus had levels of C-reactive protein significantly higher than those without. During 
pregnancy, accumulation of hormones in gingival tissues affects gingival vasculature, and 
the local immune system reaction to dental plaque [239].The increased level 
of progesterone during pregnancy may provide a favorable environment for certain 
gingivitis-causing bacteria. These increased levels of progesterone may also make gum 
tissue more sensitive to plaque, exaggerating the host response. Mittas et al. found that 
plaque accumulation during GDM might be the main reason for gingival inflammation. 
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Periodontal diseases may increase the systemic inflammatory challenge, due to 
hematogenous spread of bacteria and their products as a result of ulceration of epithelial 
cells in periodontal pockets [240, 241]. P. gingivalis and T. denticola were found at a 
significantly higher level among the pregnant women with periodontitis [221]. Recent 
metagenomic analysis studies revealed that placental microbiome profiles were similar to 
the oral microbiome [242]. P. gingivalis has been found in the amniotic fluid in addition to 
the subgingival plaque and [222]. P. gingivalis was detected in the placentas of pregnant 
women with periodontitis who had preterm deliveries [241]. There was exacerbated 
gingival inflammation in an animal model when pregnant mice were challenged with P. 
gingivalis [243]. In an animal model, P. gingivalis-derived LPS infected pregnant mice 
exhibited reduced fetal weight and increased fetal resorption [244]. Another periodontal 
pathogen, T. denticola has also been associated with pregnancy complications and poor 
pregnancy outcome [221, 222, 243, 245]. In a mouse model, it has been shown that T. 
denticola has an ability to disseminate to distant sites from the site of infection [246]. In a 
mouse subcutaneous model, it has been shown that the newly emerging periodontal 
pathogen, F. alocis has the ability to colonize and spread to distant sites [54]. 
There are many studies showing the relationship between periodontitis, GDM and poor 
pregnancy outcomes; periodontal diseases, GDM and oral pathogens; and the 
interrelationship between periodontitis and GDM. There are few studies that addressed: 
the relationship between pregnancy-associated gingivitis and oral pathogens; and GDM 
and oral pathogens. Numerous studies show that gingivitis in pregnant women can occur 
due to physiological condition rather than the accumulation of plaque. In chapter 2 we 
studied whether there exists any relationship between pregnancy gingivitis; GDM and the 





INCREASED INFECTION WITH KEY PERIODONTAL PATHOGENS DURING 
GESTATIONAL DIABETES MELLITUS 
2.1. Introduction 
Increased gingival inflammation is well documented during pregnancy [247-249], and 
periodontal diseases increase the risk for maternal (hypertension and preeclampsia) and 
fetal complications (low birth weight and pre-term birth) [250-256]. For example, active 
periodontal inflammation, as determined by bleeding on probing, has been reported to 
correlate with reductions in fetal femur length, birth weight and birth length [253]. Indeed, 
it has even been suggested that periodontal disease severity may predict adverse 
pregnancy outcome [257]. 
Gestational diabetes mellitus (GDM) occurs in 2 to more than 10% of pregnancies [258] 
and also increases the risk for pregnancy complications, such as placental abnormalities, 
pre-eclampsia, emergency cesarean delivery, and stillbirth, as well as future development 
of type 2 diabetes mellitus [259-263]. 
Diabetes and periodontal inflammation correlate, with overt diabetes associated with an 
increased risk of more severe periodontitis while periodontitis has been associated with 
worsened glycemic control in subjects with diabetes [264-267]. There are only a few 
studies that address the interrelationships of GDM and gingivitis during pregnancy, 
specifically, and exacerbation of gingival inflammation by gestational GDM [228, 268, 
269]. 
Gingivitis is a bacterial-induced disease and specific dental plaque pathogens, 
including P. gingivalis and Treponema denticola, have been associated with poor 
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pregnancy outcomes [221, 222, 240, 243, 245]. Furthermore, poor glycemic control has 
been reported to result in increased subgingival infection with these same two pathogens 
[230]. Increased low-grade systemic inflammation has been suggested to be related to 
pregnancy complications, such as preeclampsia [54, 270], with elevated levels of the 
acute phase protein, C-reactive protein (CRP), suggested to be an effective early 
biomarker for GDM [271]. 
We hypothesized that both pregnancy-associated gingivitis and gestational diabetes 
mellitus would be associated with increased oral infection with key oral pathogens and we 
set out to monitor oral infection with P. gingivalis, T. denticola, and the recently emergent 
oral pathogen, Filifactor alocis [29], as well as the systemic inflammatory burden, in 117 
pregnant women with and without gingivitis and with and without gestational diabetes. 
2.2. Materials and Methods 
Materials 
Chelex 100 was purchased from Bio-Rad Laboratories (Hercules, CA, USA), PCR primers 
came from Bio-Synthesis Inc. (Lewisville, TX, USA), while PCR SuperMix and UltraPure 
distilled water were from (Invitrogen, Carlsbad, CA, USA). Gifu anaerobic medium (GAM) 
was purchased from Nissui Pharmaceutical (Tokyo, Japan) while brain heart infusion 
(BHI) medium came from Becton Dickenson (Sparks, MD, USA). Fetal bovine serum was 
obtained from Atlanta Biologicals (Lawrenceville, GA, USA). All other media components 
came from Sigma-Aldrich (St. Louis, MO, USA). High sensitivity cotinine immunoassays 
were obtained from Salimetrics (State College, PA, USA). Finally, CRP EIA kits were 





All individuals were recruited between September 2012 and March 2013 at the 
Endocrinology and Metabolism outpatient clinic, Aydın State Hospital, Aydın, Turkey. The 
study was conducted in full accordance with ethical principles, including the World Medical 
Association's Declaration of Helsinki, as revised in 2008. The protocol was approved by 
the Ethics Committee of Medical Faculty of Ege University (protocol number 13-2/9). The 
study protocol was explained and written informed consent was received from each 
individual before enrollment in the study. Medical and dental histories were obtained from 
each individual, and saliva and serum samples were obtained before the clinical 
periodontal examination. The inclusion criteria were being in the third trimester, and having 
no other diagnosed systemic diseases requiring usage of medications such as antibiotics, 
non-steroidal anti-inflammatory drugs, corticosteroids or drugs that cause gingival 
overgrowth. Smoking status was determined according to the self-reports of the pregnant 
women and then verified biochemically by salivary cotinine analysis. The exclusion 
criterion was a body mass index (BMI) value ≥30 (kg/m2). 
Gestational diabetes mellitus was diagnosed according to the current American Diabetes 
Association criteria [272], i.e. a 75 g oral glucose tolerance test was administered, with 
fasting plasma glucose measurement at 1 and 2 h, at 24–28 weeks of gestation in women 
not previously diagnosed with overt diabetes. GDM was diagnosed if the following 
threshold values were met: fasting, ≥92 mg/dl (5.1 mmol/l); 1 h, ≥180 mg/dl (10.0 mmol/l); 
and 2 h, ≥153 mg/dl (8.5 mmol/l). 
Gingivitis was diagnosed as previously described [273-275], i.e., when bleeding on 
probing (BOP) was present at >50% of all sites and probing depth (PD) was <3 mm at 
≥90% of the measured sites, no more than one site with a PD >4 mm and clinical 
attachment level (CAL) ≤1 mm. All participants had ≥20 teeth present. Periodontally 
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healthy women were required to present with <30% BOP, and no clinical sign of alveolar 
bone loss. Plaque index (PI) was recorded as present or absent following visual 
examination [276]. 
Saliva and serum sampling 
Whole, unstimulated saliva samples were obtained, before any clinical measurement or 
periodontal intervention, by expectoration into polypropylene tubes in the morning, 
following an overnight fast, during which participants were requested not to drink (except 
water) or chew gum, essentially as previously reported [277]. The saliva samples were 
clarified by centrifugation (800 g) for 10 min at room temperature, and 500 μl amounts 
were placed in polypropylene tubes, and immediately lyophilized Venous blood (5 ml) was 
taken from the antecubital vein by standard venipuncture. Serum was separated by 
centrifugation at 1500 g for 10 min and immediately frozen at −40°C then lyophilized. 
Samples were shipped to the University of Louisville for biochemical and microbiological 
analysis. Ethical approval to analyze biomedical samples originating in Turkey was 
obtained from the Institutional Research Board of the University of Louisville (protocol 
number 13.0670). 
Determination of systemic CRP concentrations 
Circulating CRP was measured in serum using EIA kits, according to the manufacturer's 
instructions (Cayman Chemical Co.), using an Emax Precision Microplate Reader 





Determination of salivary cotinine concentrations 
Salivary cotinine was measured using a high sensitivity cotinine immunoassay 
(Salimetrics) and an Emax Precision Microplate Reader, as previously reported [277]. The 
reported sensitivity of the assay is 0.15 ng/ml. 
Growth of periodontal pathogens 
P. gingivalis ATCC 33277; F. alocis ATCC 38596; and T. denticola ATCC 35405 were 
grown to mid-to-late log phase at 37°C (80% N2, 10% H2, 10% CO2) in GAM; BHI 
supplemented with FBS (5%), L-cysteine (0.1%) and arginine (20%); and new oral 
spirochete broth (with veal heart infusion replaced with BHI and KH2PO4 omitted) [278], 
respectively, in an anaerobic chamber (Coy Laboratories, Grass Lake, MI, USA). 
Detection of pathogens 
The presence or absence of bacterial DNA was determined by four PCR amplifications 
per Chelex 100 (25% mass/volume)-treated saliva sample, using primers documented in 
Table 1. Cycling parameters were as previously reported [277, 279, 280]. DNA extracted 
from cultured periodontopathogens and water served as positive and negative controls, 
respectively. P. gingivalis, T. denticola, F. alocis and universal 16S rRNA amplicons were 
visualized using the Lonza Flashgel system (Rockland, ME, USA). 
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Table 1: Primers used to detect bacterial DNA in saliva 
 
Data analyses 
The sample size was based on precedent literature examining the relationships between 
diabetes, pregnancy, CRP concentrations and infection with oral pathogens [229, 230, 
240, 271, 281]. Statistical significance was determined using Instat v3.06 (GraphPad, 
San Diego, CA, USA). Parametric or nonparametric ANOVA with Tukey or Dunn post-
testing, respectively, and Fisher's Exact Test were employed, as appropriate. 
Correlations between measurements of interest were determined by Spearman rank 
analysis. Significance was set at p ≤ 0.05. 
2.3. Results 
The characteristics of all recruited women are shown in Table 2. The periodontally healthy 
group with GDM was older than the periodontally healthy group without GDM by an 
average of 3.4 years. As expected, all clinical parameters were higher in those with 
gingivitis compared to the periodontally healthy women while those with GDM had a higher 
BMI than those who did not. By chance, the groups were matched for smoking (smoking 
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yes versus no). Furthermore, there was no correlation between cotinine concentration and 
BoP (p = 0.636), perhaps due to the small number of smokers and low cotinine 
concentrations. 
Table 2: Characteristics of the study population 
Women with gingivitis during pregnancy are more likely to harbor 
periodontopathogens 
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As expected, because gingivitis is a bacteria-induced disease, pregnant subjects with 
gingivitis were more likely to harbor periodontopathogens than those who were 
periodontally healthy, as shown in Table 3. 
 
Table 3: Infection with periodontal pathogens. 
Women with gestational diabetes mellitus are more likely to harbor 
periodontopathogens 
Gestational diabetes mellitus itself was associated with increased infection 
with P. gingivalis, F. alocis, T. denticola, or a multiplicity of infection of individuals both 
with and without gingivitis, as shown in Table 3. 
Gingivitis dramatically elevates systemic CRP in pregnant women 
The systemic inflammatory burden, as determined by CRP measurement, was higher in 
those with gingivitis only compared to those without gingivitis (with or without GDM, 
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both p < 0.01) but not those with gingivitis and GDM, as shown in Figure 1. The mean 
(SD) CRP concentrations for those without gingivitis or GDM, with gingivitis only, with 
GDM only and those with both gingivitis and GDM, was 2495 (3007); 8386 (10006); 1838 
(1389); and 8698 (4938) ng/ml, respectively. There was no correlation between cotinine 
concentration and CRP (p = 0.835), again perhaps due to the small number of smokers 
and low cotinine concentrations. Similarly, there was no correlation between BMI and CRP 
(p = 0.265) for the total population, likely reflecting the importance of gingival 
inflammation. 
 
Figure 1: Systemic Inflammation (CRP) is elevated in pregnant women with 
gingivitis. The systemic CRP burden in women with and without gingivitis and 




A recent systematic review of the available epidemiological evidence determined that 
maternal periodontitis is independently associated with adverse pregnancy outcome, but 
that interpretation of the data is impacted by disease definition [282], a conclusion 
supported by a recent study [283]. Increased bacterial infection and systemic inflammation 
related to moderate and severe periodontitis are each risk factors for poor pregnancy 
outcome [248, 284, 285]. Specific microbial signatures of the subgingival biofilm were able 
to distinguish between microbiomes of periodontal health, gingivitis and periodontitis and 
these profiles may be helpful in establishing the risk of disease [286]. Herein, we 
specifically address the interactions of a different type of periodontal disease, gingivitis, 
and GDM. 
Infection with periodontal bacteria has been reported to be an important indicator of poor 
pregnancy outcome, particularly pre-term and/or low birth weight infants [240, 287-290]. 
P. gingivalis is an anaerobic, Gram-negative bacterium and a causative agent of chronic 
periodontitis that is associated with several systemic sequelae, including pregnancy 
complications [222]. Even at low colonization levels, P. gingivalis employs a variety of 
strategies to control the commensal microbiota and direct disease progression and is thus 
regarded as a keystone species [19]. T. denticola, a highly motile, invasive, Gram-
negative anaerobe, is also a causative agent of periodontitis that has been associated 
with pregnancy complications [245]. F. alocis is an anaerobic, Gram-positive bacterium, 
that has recently been identified by human microbiome projects as a pathogen associated 
with chronic periodontitis, aggressive periodontitis and endodontic lesions [56]. The 
potential relationship between F. alocis and maternal or fetal health, to the best of our 
knowledge, has not been examined. 
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From a mechanistic perspective, P. gingivalis has been the most extensively studied oral 
microbe. For example, injection of anti-P. gingivalis antibodies that are cross-reactive with 
cardiolipin into the tails of pregnant mice have been shown to increase fetal loss, relative 
to control antibody [291]. Administration of P. gingivalis-derived LPS to mice reduces fetal 
weight and increases fetal resorption [244]. Furthermore, P. gingivalis DNA has been 
found in chorionic tissues of high-risk pregnant women [292] and in the amniotic fluid of 
women bearing pre-term and/or low birth weight infants [240]. 
Saliva collection is more convenient, and thus likely to facilitate more ready recruitment 
than the isolation of subgingival dental plaque samples, while there are multiple reports 
that subgingival bacteria can be readily monitored in saliva and, furthermore, that bacteria 
detected in saliva correlate with periodontal disease status [293-295]. Therefore, saliva, 
rather than plaque, was employed herein. A high rate of infection with the emerging 
pathogen, F. alocis (48.1–76.3%) and the established but understudied 
pathogen, T. denticola (61.3–86.8%) was observed in all subject groupings. Despite this 
high background, gingivitis during pregnancy increased infection with periodontal 
pathogens in women with and without GDM. In those without GDM, gingivitis was 
associated with an increased frequency of detection of DNA from P. gingivalis, F. alocis, 
and combinations of the three targeted bacteria. In those with GDM, gingival inflammation 
resulted in increased infection with P. gingivalis, T. denticola, and combinations of the 
three targeted bacteria. 
GDM itself increased the likelihood of infection with periodontopathogens in those with 
and without gingivitis during pregnancy. In those without gingivitis, GDM was associated 
with an increased frequency of detection of DNA from F. alocis and combinations of the 
three targeted bacteria. In those with gingivitis, GDM was associated with increased 
infection with P. gingivalis, T. denticola, and combinations of the three targeted bacteria. 
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Thus, gingivitis and GDM each increase the incidence of infection with 
periodontopathogens, an established risk factor for pregnancy complications. 
Increased systemic inflammation has been suggested to be related to pregnancy 
complications, such as preeclampsia [54, 270], with elevated levels of the acute phase 
protein, C-reactive protein (CRP), reported to be an effective early biomarker for GDM 
[271]. All women were recruited during the third semester, the stage of pregnancy when 
CRP levels have been reported to be highest in those with GDM [237]. In women with 
periodontitis and pre-eclampsia, [296] it was found that CRP levels reflected periodontal 
disease severity. Here, we establish that CRP, employed as a biomarker of systemic 
inflammation, is dramatically elevated in women with gingivitis during pregnancy, 
irrespective of GDM diagnosis. CRP concentration is hypothesized to be related to fat 
deposition and BMI only in early pregnancy, with impaired glucose metabolism important 
only later in gestation [237, 297, 298]. Therefore, it is important to note that enrolled 
women with GDM had significantly higher mean BMI than those without GDM. In baboons, 
[299] have reported that immunoglobulin responses to oral bacteria (Fusobacterium 
nucleatum, P. gingivalis, Aggregatibacter actinomycetemcomitans and   Campylobacter 
rectus) were associated with systemic inflammation during ligature-induced periodontitis 
in pregnancy [299]. 
It will be important to confirm these results in a larger population to ensure that the sample 
size (four groups of 21–38 subjects each) has not affected results such as CRP-BMI or 
smoking-CRP associations. In conclusion, and considering this limitation, these data 
suggest a bidirectional relationship between GDM and gingivitis, although, it has yet to be 
established if this concerted influence results in poor pregnancy outcome per se. 
Nevertheless, GDM and gingivitis are each associated with increased infection from 
pathogenic oral bacteria, while gingivitis increases systemic inflammation, irrespective of 
 36 
GDM. The present study focuses on microbiological data and CRP level with regard to 
GDM and gingivitis. Further biochemical analysis of cytokine and collagenase levels are 
planned in the same study population. 
Unfortunately, while intensive oral hygiene can be effective in decreasing gingivitis 
during pregnancy [300], women appear to receive less than their normal dental care 
when pregnant [301]. If confirmed, these results suggest that increased efforts to control 
gingivitis and glycemic control during pregnancy may help to reduce two important risk 
factors for poor pregnancy outcomes. 















COMPARISON OF INHERENTLY ESSENTIAL GENES OF PORPHYROMONAS 
GINGIVALIS IDENTIFIED IN TWO TRANSPOSON-SEQUENCING LIBRARIES 
3.1. Introduction 
Periodontitis, a microbially-driven, destructive disease of the tissues surrounding the teeth 
occurs in approximately 50% of the population [302]. Increasing evidence suggests that 
periodontitis is associated with elevated risk of vascular diseases, including coronary 
artery disease and stroke, diabetes mellitus, lung diseases such as chronic obstructive 
pulmonary disease and pneumonia, rheumatoid arthritis, preterm low birth weight delivery, 
and even some forms of cancer [303-307].  
The anaerobic, Gram-negative bacterium P. gingivalis is an emerging systemic pathogen 
and a causative agent of chronic periodontitis. P. gingivalis has been proposed as the 
prototypic oral keystone pathogen [17], that is, a bacterium that promotes dysbiosis and 
inflammation-driven tissue destruction even at low levels of infection. P. gingivalis ATCC 
33277 is one of the most commonly employed strains in periodontal research and is 
pathogenic in experimental animals following oral infection [137]. The P. gingivalis ATCC 
33277 genome is comprised of 2155 genes, 2090 of which encode proteins, and there are 
no plasmids [32, 147, 148]. Recently, Klein et al [148] generated a Mariner transposon 
insertion mutant (TnSeq) library (which we denote Library 1) for this P. gingivalis strain 
and used it to identify 463 genes potentially required for in vitro viability. We have 
independently generated a TnSeq mutant library for P. gingivalis ATCC 33277 (Library 2), 
building on our previous work on Vibrio and Pseudomonas gene fitness [308-310]. 
There is no fully defined medium for P. gingivalis, and different complex media are likely 
to provide different nutritional environments. Therefore, we hypothesized that multiple 
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genes essential for planktonic growth in complex media would be common (i.e. potentially 
representing the core genome) and divergent (i.e. environment-specific) between Library 
1 and Library 2. 
3.2. Materials and Methods 
Materials 
P. gingivalis ATCC 33277 was cultured in Gifu anaerobe medium (GAM; Nissui 
Pharmaceutical, Tokyo, Japan) and on GAM blood agar. Escherichia coli DH5α and 
pSAM_Bt were cultured in Luria–Bertani broth and agar from BD Biosciences (San Jose, 
CA). Sheep blood was from Lampire Biological Laboratories (Pipersville, PA). Gentamicin, 
erythromycin, ampicillin, dichloromethane, sodium sulfate and analytical nicotine 
standards were from Sigma-Aldrich (St. Louis, MO). GeneReleaser® came from Bio 
Ventures, Inc. (Murfreesboro, TN). All primers were from Biosynthesis Inc. (Lewiston, TX). 
Lonza flash gels came from Lonza (Rockland, ME). Wizard SV and PCR clean-up kit were 
from Promega (Madison, WI). T4 DNA Ligase and buffer; MmeI; and TAE buffer came 
from New England Biolabs (Ipswich, MA), while HiFi Hotstart Readymix was from KAPA 
Biosystems (Wilmington, MA) and the polymerase chain reaction (PCR) SuperMix came 
from Invitrogen (Carlsbad, CA). 
Generation and validation of a P. gingivalis ATCC 33277 transposon sequencing 
library 
An ATCC 33277 mariner transposon insertion library was generated. P. gingivalis was 
inoculated into GAM without antibiotics; E. coli strain DH5α containing the pSAM_Bt 
plasmid was grown in Luria–Bertani broth with ampicillin; and a 5:1 ratio of log 
phase P. gingivalis to E. coli was employed for conjugation. pSAM_Bt was originally 
employed to generate the first TnSeq library in the porphyromonad-related 
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microbe, Bacteroides thetaiotaomicron [311]. Gentamicin (E. coli is 
sensitive; P. gingivalis is naturally resistant) and erythromycin (resistance is transposon-
encoded) were used to select for insertion mutants grown on GAM/blood agar plates. 
Random insertion in the P. gingivalis genome was confirmed by nested semi-random 
PCR. One hundred randomly selected colonies were harvested to test for hot spots of 
insertion of the transposon by semi-nested PCR involving two rounds of PCR. DNA was 
harvested from selected colonies by GeneReleaser® following the manufacturer's 
protocol. Round one PCR was performed with Invitrogen Supermix using Round 1-pSAM 
and Round 1-RndomPG primers (Table 7) under the following conditions: 94°C for 3 min; 
94°C for 30 s, 50°C for 40 s, 72°C for 3 min, 10 cycles; 94°C for 30 s, 62°C for 40 s, 72°C 
for 3 min, 25 cycles. Round one PCR products were used for round two PCR amplification 
using Round 2-PG and Round 2-pSAM primers (Table 7) under the following conditions: 
94°C for 3 min; 94°C for 30 s, 57°C for 40 s, 72°C for 3 min, 30 cycles; 72°C for 5 min. 
Amplicons were run on a Lonza flash gel system to verify correct fragment size. 16S rRNA 
gene-specific primers (Table 7) were also used to confirm P. gingivalis specificity with the 
same cycle conditions as round 2 of the nested PCRs employed. 
Identification of essential genes for planktonic growth in GAM 
The mutant library was passaged twice after the culture reached mid-late log phase in 
1 liter of GAM broth containing gentamicin (50 μg ml−1) and erythromycin (5 μg ml−1). 
Genomic DNA from the mutant library (100 μg) was harvested using the Wizard DNA 
isolation kit and digested with MmeI (1 h at 37°C; 20 min at 80°C). The DNA digest was 
run on a 1% agarose gel and the band corresponding to the transposon plus the flanking 
sequences (~1500) was extracted using a Wizard gel extraction kit, as per the 
manufacturer's instructions. A double-stranded DNA adapter was created using the 
primers LIB_AdaptT_4 and LIB_AdaptB_4 (Table 7). The primers were combined and 
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heated at 95°C for 5 min and then allowed to cool to room temperature. The dsDNA 
adapter was ligated to the gel purified DNA product using T4 DNA ligase (16 h at 16°C; 
10 min at 65°C). Ligation products purified by a Wizard purification kit and amplified by 
PCR using HiFi Hotstart SuperMix with LIB_PCR_5 and LIB_PCR_3 primers (Table S1) 
under the following conditions: 98°C for 3 min; 98°C for 20 s; 60°C for 1 min; 72°C for 
1 min, 18 cycles; 72°C for 4 min. The PCR product was purified using a Wizard purification 
kit and run on a Lonza flash gel system to verify the 125-base-pair band. Products were 
quantified using a NanoDrop ND-1000 spectrophotometer (Wilmington, DE) and 
sequenced at the University of Michigan DNA Core. The sequences were read by 50-
base-pair single end reads. The prepared mutant library DNA was run on a single flow cell 
lane on the Illumina HiSeq2000 platform. The resulting reads were analyzed by 
CLC Genomics Workbench 7.1.1. Adapter sequences were removed along with the 
sequence corresponding to the end of the transposon. All sequences with reads with a 
quality score <0.05 or of <15 nucleotides were removed. The remaining reads were 
aligned to the annotated gene list of P. gingivalis strain ATCC 33277. To control for 
variations in gene length and depth of coverage, normalized genes with <0.5 reads per 
kilobase per million (RPKM) mapped reads were considered essential. The remaining 
genes were determined to be non-essential for survival in GAM broth. 
Cross library comparison of essential genes for planktonic growth in complex 
media 
The genes essential for survival in GAM broth were compared with the previously 
published list of essential genes for survival in supplemented brain–heart infusion broth 
[148]. The function and interrelationships of the 281 common inherently essential genes 
for planktonic growth of P. gingivalis in complex media were investigated in silico by 
KEGG (www.genome.jp/kegg) database analyses. The common essential genes were 
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mapped to the P. gingivalis ATCC 33277 genome using CGViewer 
(Stothard.afns.ualberta.ca/cgview_server/) [312] and compared with the Database of 
Essential Genes (DEG; tubic.tju.edu.cn/deg/, blastx search, <1e-8) [313]. 
3.3. Results 
Random insertion in the P. gingivalis ATCC 33277 genome, which contains ~117,000 TA 
sites distributed among 2155 genes, was confirmed by nested semi-random PCR, as 
shown in Figure 2. Inherently essential genes common to Library 1 and Library 2 were 
mapped to the P. gingivalis ATCC 33277 genome using CGViewer, as presented in 
Figure 3. KEGG analysis (www.genome.jp/kegg) was employed to functionally classify the 
same P. gingivalis gene set, as noted in Table 4. The highest percentage of essential 
genes found within the functional groupings was for those whose products are involved in 
protein export, 89% of which were essential under these conditions. Similar functional 
groupings were obtained using the DAVID database (https://david.ncifcrf.gov). Functional 
relationships between the common essential genes were determined, using KEGG, as 
shown in Fig. 4a–e. Finally, the complete database of 281 common genes is provided in 





Figure 2: Validation of TnSeq library. (A) 16S rDNA confirmation of P. gingivalis; 
expected band size of 463 bp(B) random insertion determined by nested 
polymerase chain reaction (lanes from 100 randomly selected colonies). 
Approximately 80,000 insertion strains (individual mutants) were generated in the 
ATCC 33277 chromosome. 
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Figure 3: Map of putative common inherently essential genes for the planktonic 
growth of P. gingivalis in complex media. Common essential genes were mapped 
to the P. gingivalis ATCC 33277 genome using CG viewer (Grant& Stothard,2008). 
The blue arrows show the location of the 281-putative common essential genes 
within the P. gingivalis 33277 chromosome. The adjacent two rings depict gene 
orientation (outer and inner blue arrows represent the positive and negative 
strands, respectively). The next two rings represent the coding sequences for P. 




Table 4: Functional classification of inherently essential genes of P. gingivalis 







Figure 4a. Pyrimidine Metabolism (pathway enriched among inherently essential 
P. gingivalis genes). KEGG pathways (www.genome.jp/kegg) are presented with 
the proteins catalyzing each step shown by their enzyme commission number and 
substrates/products. Green shading indicates the presence of homologs in P. 
gingivalis. The red star denotes essential genes. The PGN assignments of the 




Figure 4b. Lipopolysaccharide Biosynthesis (pathway enriched among inherently 
essential P. gingivalis genes). KEGG pathways (www.genome.jp/kegg) are 
presented with the proteins catalyzing each step shown by their enzyme 
commission number and substrates/products. Green shading indicates the 
presence of homologs in P. gingivalis. The red star denotes essential genes. The 







Figure 4c. Peptidoglycan Biosynthesis (pathway enriched among inherently 
essential P. gingivalis genes). KEGG pathways (www.genome.jp/kegg) are 
presented with the proteins catalyzing each step shown by their enzyme 
commission number and substrates/products. Green shading indicates the 
presence of homologs in P. gingivalis. The red star denotes essential genes. The 





Figure 4d. Pantothenate and CoA Biosynthesis (pathway enriched among 
inherently essential P. gingivalis genes). KEGG pathways (www.genome.jp/kegg) 
are presented with the proteins catalyzing each step shown by their enzyme 
commission number and substrates/products. Green shading indicates the 
presence of homologs in P. gingivalis. The red star denotes essential genes. The 
PGN assignments of the essential metabolic genes are provided in Table 9. 
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Figure 4e. Nicotinate and Nicotinamide Metabolism (pathway enriched among 
inherently essential P. gingivalis genes). KEGG pathways (www.genome.jp/kegg) 
are presented with the proteins catalyzing each step shown by their enzyme 
commission number and substrates/products. Green shading indicates the 
presence of homologs in P. gingivalis. The red star denotes essential genes. The 
PGN assignments of the essential metabolic genes are provided in Table 9. 
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 Table 5: Inherently essential genes of P. gingivalis identified in two transposon 














Library 1 (Klein et al. 
2012) 
Brain-heart infusion (unspecified concentration), yeast 
extract (1 mg/ml), hemin (5 µg/ml), menadione (0.5 µg/ml), 
sodium bicarbonate (1 mg/ml), sodium thioglycolate (0.25 
mg/ml), cysteine (0.5 mg/ml). Gentamicin (25-50 mg/ml) 
and erythromycin (2-10 mg/ml) also employed. 
Gifu Anaerobe 
Media (GAM) 
Library 2 (herein) 
Peptic digest of animal tissue (10 mg/ml), papaic digest of 
soyabean meal (3 mg/ml), proteose peptone (10 mg/ml), 
digested serum (13.5 mg/ml), yeast extract (5 mg/ml), 
beef extract (2.2 mg/ml), liver extract (1.2 mg/ml), 
dextrose (3 mg/ml), H2KO4P (2.5 mg/ml), NaCl (3 mg/ml), 
soluble starch (5 mg/ml), L-cysteine hydrochloride (0.3 
mg/ml), and sodium thioglycolate (0.3 mg/ml). Gentamycin 
(50 µg/ml) and erythromycin (5 µg/ml) also employed. 
 
Table 6: Composition of (A) BHIHKSbcStgC and (B) GAM complex media 








ID Sequence(5’ -> 3’) 
Pg16S-F AGG CAG CTT GCC ATA CTG CG 
Pg16S-R ACT GTT AGC AAC TAC CGA TGT 
LIB_PCR_5 CAA GCA GAA GAC GGC ATA CGA AGA CCG GGG 
ACT TAT CAT CCA ACC TGT 
LIB_PCR_3 AAT GAT ACG GCG ACC ACC GAA CAC TCT TTC 
CCT ACA CGA CGC TCT TCC GAT CT 
Round 1-
RndomPG-1 
















GGC CAC GCG TCG ACT AGT AC NNNNNNNNND 
CAGCAG 
Round1-pSAM TCG AGG GCG CGC CAA GCA G 
Round2-PG GGC CAC GCG TCG ACT AGT AC 
Round2-pSAM CGC GCC AAG CAG AAG ACG GCA TAC G 
LIB_AdaptT_4 TTC CCT ACA CGA CGC TCT TCC GAT CTT TTC 
CNN 
LIB_AdaptB_4 GGA AAA GAT CGG AAG AGC GTC GTG TAG GGA A 
                                 



















A comparison of two independently generated TnSeq libraries for P. gingivalis ATCC 
33277 suggests that 281 common genes are essential for in vitro growth in two complex 
media. This minimal P. gingivalis genome is rich in genes performing critical physiological 
processes, particularly pyrimidine metabolism as well as lipopolysaccharide, 
peptidoglycan, and coenzyme A biosynthesis. Those genes that encode established 
virulence factors, such as gingipains [101], fimbriae [314], capsule [105], and RagB [315], 
are underrepresented in this overlapping gene set, probably because there is no immune 
or competing microbial challenge to be met. In other words, they are likely to be 
conditionally essential rather than inherently essential. Hence it could be reasoned that, 
while targeting P. gingivalis components that drive pathogenesis in vivo is a valid 
approach, the rather more mundane set of essential genes identified herein may prove to 
be more efficacious in controlling P. gingivalis infections. It should be noted that the 
‘essential’ gene set can change depending on the growth conditions. Some genes will 
likely be required in all conditions (e.g. rpoN and lepB, identified herein) but the 
importance of others will depend on the nutritional content of the medium, i.e. conditionally 
essential genes. In the long-term, a comparison of inherently essential genes and genes 
essential in multiple conditions will facilitate optimization of potential therapeutic targets. 
In addition to the elucidation of genes grouped into metabolic pathways, there are other 
essential genes that are interesting at the individual level. The rpoN gene (PGN_1202, 
33277; PG1105, W83 orthologue; PGTDC60_1103, TDC60 orthologue), for example, 
encodes the alternative sigma factor, σ54. Bacteroides spp. are rich in extracytoplasmic 
sigma factors compared with other Bacteroidetes [316]. These sigma factors form part of 
the RNA polymerase holoenzyme and control transcriptional specificity. σ54 is commonly 
used for large-scale transcriptional changes by binding to different and more highly 
 55 
conserved consensus sequences than those for σ70 [317]. Furthermore, although there 
are multiple members of the σ70 family – and the σ70 factor rpoD (PGN_0638; PG0594; 
PGTDC60_1719) is also essential – there is only one member of σ54. Interestingly, rpoN is 
not typically an essential gene in most systems. The only described instance 
where rpoN has been shown to be essential in the soil bacterium, Myxococcus 
xanthus [318]. Why the P. gingivalis rpoN gene is essential for in vitro growth remains to 
be determined. 
The heat-shock protein 60 homolog, groEL (PGN_1452; PG0520; PGTDC_1639), is an 
emergent P. gingivalis virulence factor that has been proposed to promote cytokine 
production and inflammation, to enhance osteoclastogenesis, to aid in the vascularization 
of tumors and, perhaps, to play a role in atherosclerosis [319-322]. Although PGN_1452 
is not itself essential, the groEL co-chaperone, groES (PGN_1451; PG0520; 
PGTDC60_1640) is required for growth in complex media. Another heat-shock protein 
family member, dnaJ (PGN_1716; PG1776; PGTDC60_1360), and the gene encoding the 
DnaK repressor (PGN_0516; PG1597; PGTDC60_0704) are further common essential 
genes. 
There are several proteolytic genes common to Library 1 and Library 2. These are genes 
encoding: signal peptidase I (lepB; PGN_1946; PG1598; PGTDC60_0703); signal 
peptidase II (lspA; PGN_0515; PG2001; PGTDC60_0274); as well as an aminoacyl-
histidine dipeptidase (PGN_0250; PG0137; PGTDC60_0414); and a leucine 
aminopeptidase (PGN_0202; PG2157; PGTDC60_1640) that is related to the M28 group 
of metalloproteinases. P. gingivalis contains only a single copy each of lepB and lspA, 
which are required for protein translocation across cell membranes, consistent with the 
finding that these signal peptidases form part of the core genome. Additionally, the 
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majority of Sec-related protein export genes were also essential 
(secY, secE, secG, secD/F, yajC, SecA, SRP54/ffh, and ftsY but not yidC). 
Multiple genes that control bacterial shape, including those encoding RodA (PGN_0626; 
PG703; PGTDC60_0579 and PGN_0870; PG1392; PGTDC60_2072), as well as MreB 
(PGN_0866; PG1396; PGTDC60_2068), are also common inherently essential genes. 
Interestingly, mreB is not usually an essential gene for most rod-shaped bacteria. Perhaps 
the essentiality of mreB in P. gingivalis in laboratory media suggests a need to maintain a 
rod shape to keep the surface area-to-volume ratio lower than that for a coccus. 
Upon interrogation of the Database of Essential Genes, it is clear that 
some P. gingivalis ATCC 33277 genes have common essential homologs whereas others 
are unique (n = 54; 19%) to this bacterium. Eighty-three (30%) genes have ≤10 essential 
homologs, while 11 (n = 4%) have ≥50 homologs. Although it must be acknowledged that 
the current database of known essential prokaryotic genes is limited to 36 bacterial 
species other than P. gingivalis – because of the recent emergence of TnSeq technology 
– the combination of common and unique required genes suggests that, in the long term, 
it may be possible to generate both broad-spectrum and P. gingivalis-specific therapeutic 
targets for the control of bacterial infections. 
Differential phenotypes are sometimes reported for the same bacterial strains. Although 
this can be partly explained, for example, by different model systems or the propagation 
of relevant mutant genes within laboratory collections, the comparison of Library 1 and 
Library 2 raises another possibility. Despite the fact that both libraries 
are P. gingivalis ATCC 33277-specific, approximately half of the genes identified in 
Library 1 were not common to Library 2. Considering that both libraries lack transposon 
insertion hot spots and contain large mutant numbers (54,000 and 80,000 colonies, 
respectively), the major difference between the experimental setups is the composition of 
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the complex growth media employed (Table 6). As different nutritional and other needs 
may be met by each of these complex media, this may be sufficient to induce considerable 
differences in the adaptive response to such growth conditions, reflected in the different 
profiles of essential genes. Performing similar analyses on other bacterial pathogens to 
distinguish between inherently essential and conditionally essential genes may reveal 
additional targets for new therapeutics. 
In summary, we have identified 281 genes that are essential for in vitro survival of the 
periodontal pathogen P. gingivalis as defined by two independently generated TnSeq 
mutant libraries. It is expected, following validation of these genes by determining the 
growth characteristics of essential gene deletion mutants and their complements, that 
some of these required genes will represent novel therapeutic targets for the efficient 













IDENTIFICATION OF GENES ESSENTIAL FOR PORPHYROMONAS GINGIVALIS 
SURVIVAL UNDER THE CONDITION OF CIGARETTE SMOKE INDUCED STRESS  
4.1. Introduction 
There are >1.3 billion smokers in the world (177). Smoking alone accounts for most cases 
of periodontitis in adults in developed nations, like Scandinavia, New Zealand and the U.S. 
[323-326]. Smokers exhibit reduced clinical signs of inflammation. In smokers, host- and 
bacterial-derived tissue degrading proteinases enhance periodontal destruction [327-334]. 
Results of several cross-sectional and longitudinal studies showed smoking as a major 
environmental risk factor associated with the development of extensive and severe 
periodontal diseases [159, 198, 201, 335, 336]. Smoking results in periodontal destruction 
in a dose-dependent manner [337, 338]. Probing pocket depths and tooth mobility scores 
were highest among smokers having periodontitis [339, 340]. Oxygen tensions in 
periodontal pockets are lower in smokers compared to non-smokers [171]. In smokers, 
there is a chronic reduction of blood flow, altered neutrophil function, altered cytokine and 
growth factor production, inhibition of fibroblast growth and attachment, decreased 
collagen production and vascularity in the oral cavity, but increased levels of free radicals 
and lipid peroxidation in periodontal tissues, and alteration in osteoclast activity [339, 341]. 
All these changes affect the pathogenesis of periodontal diseases and healing of the 
periodontium after periodontal treatment in smokers. Thus, the local oral environment in 
smokers is different from that of non-smokers. These changes in the oral environment 
might exert selective pressure on the oral biofilms and in turn, lead to the selection of a 
specific group of microorganisms. 
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Many recent studies have established that cigarette smoke considerably affects 
subgingival bacterial ecology. Smokers demonstrate a pathogen-rich, commensal-poor, 
anaerobic, and dysbiotic oral microbiome, even in periodontally healthy individuals [342]. 
Despite the conflicting reports regarding the influence of smoking on the oral microbiome, 
the microbial profile of smokers having periodontitis is distinct from that of non-smokers 
[200, 342-344]. These studies suggest that there exists an association between smoking 
and subgingival dysbiosis. Dysbiosis in smokers plays a significant role in the increased 
severity of periodontitis [345]. 
In a study by Coretti et al., analysis of the putative biological functions of subgingival 
microbial communities in smokers having periodontitis, non-smokers with periodontitis 
and healthy individuals was performed [345]. In the microbiota of healthy subjects, 
enzymes for biosynthesis and biodegradation of secondary metabolites, fatty acid 
metabolism, and amino acid biosynthesis were upregulated. In smokers having 
periodontitis, there was enrichment of genes encoding peptidases, enzymes for 
lipopolysaccharide biosynthesis, and proteins involved in cell motility and secretions 
compared to control subjects. Enrichment of such genes, suggests that there is enhanced 
virulence of subgingival microbiota in smokers compared to the healthy individuals. 
Further, in smokers having periodontitis, enzymes involved in cell motility and secretion, 
homologous recombination, peptidase, and DNA replication were over-represented in the 
subgingival microbiota compared to non-smokers with periodontitis. In a study done by 
Bagaitkar et al., it has been shown that CSE significantly influences the expression of 
6.8% of the P. gingivalis genome, as determined by whole genome arrays [180]. These 
included genes regulating capsule and fimbriae, corresponding to the reduced pro-
inflammatory potential of P. gingivalis; oxidative stress and DNA repair. P. gingivalis 
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adapts to the environmental stress presented by CSE by altering the expression of several 
genes and outer membrane proteins [180].  
Despite information regarding various virulence factors of P. gingivalis and their host 
interactions at the phenotypic level, the genes essential for the survival of P. gingivalis in 
smokers have not been identified. In this study, we plan to identify the genes of P. 
gingivalis ATCC 33277 that are essential in cigarette smoke conditioned GAM using 
massively parallel sequencing technology [103, 311, 346, 347]. Due to the quantitative 
nature of massively parallel sequencing, the fitness of a gene knockout can be 
quantitatively determined and is a direct measure of the growth rate of the bacterial clone 
containing it. The obtained information, in turn, might help us to gain information regarding 
the metabolic pathways and adaptation mechanisms. Hence, the study of genes 
regulating various virulence factors under the influence of cigarette smoke extract is of 
interest in this project. Wwe are interested in identifying the genes necessary for the 
survival of P. gingivalis in cigarette smoke-exposed GAM (Gifu anaerobic media) through 
the construction and analysis of transposon mutant libraries. We further hypothesized that 
we could verify conditional essentiality by the establishment of reduced relative growth of 
a subset of specific bacterial mutants when competed against the parent P. gingivalis 
strain under conditions of CSE-induced stress. 
4.2. Materials and Methods  
Materials 
P. gingivalis ATCC 33277 Tnseq library generated in Chapter 3 was cultured in Gifu 
anaerobe medium (GAM; Nissui Pharmaceutical, Tokyo, Japan), liquid GAM conditioned 
with the cigarette smoke extract or on GAM-blood agar. Sheep blood was obtained from 
Lampire Biological Laboratories (Pipersville, PA). Gentamicin, erythromycin, tetracycline, 
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ampicillin, dichloromethane, sodium sulfate and analytical nicotine standards were from 
Sigma-Aldrich (St. Louis, MO). All primers were from Biosynthesis Inc. (Lewiston, TX). 
Lonza flash gels came from Lonza (Rockland, ME). Wizard SV and PCR clean-up kit were 
from Promega (Madison, WI). T4 DNA Ligase and buffer; MmeI; and TAE buffer came 
from New England Biolabs (Ipswich, MA), while HiFi Hotstart Ready mix was from KAPA 
Biosystems (Wilmington, MA) and the polymerase chain reaction (PCR) SuperMix came 
from Invitrogen (Carlsbad, CA). Fast digest restriction enzymes, T4 DNA ligase, ready to 
use x-gal and plasmid isolation kit came from Thermoscientific. High-efficiency 
transformation neb alpha cells came from BioEngland. DNA yields were quantified using 
a NanoDrop ND-1000 spectrophotometer (Wilmington, DE). We obtained P. gingivalis 
strains with mutations in PGN_1524, PGN_1474, PGN_0770, PGN_0714, PGN_0491, 
PGN_0287, or PGN_0088 from Dr. Richard J Lamont (University of Louisville). We 
obtained P. gingivalis PGN_1200, PGN_1444, or PGN_0898 mutant strains from Dr. Jan 
S Potempa (University of Louisville). 
Conditioning GAM with cigarette smoke extract (CSE) 
GAM was conditioned using standard reference cigarettes (2R1, Kentucky Tobacco 
Research, and Development Center). By using a three-way stopcock and a syringe, GAM-
CSE was prepared by drawing cigarette smoke through 50 ml of the medium, with 35 ml 
drags performed every 20 seconds. GAM-CSE was then filtered (0.2 mm). Nicotine 
content was determined by gas-liquid chromatography and adjusted to pH 7.2 and 1000 
ng/ml nicotine concentration. P. gingivalis ATCC 33277 TnSeq library was grown in their 
respective control and cigarette smoke extract conditioned media under anaerobic 
conditions (80% N2, 10% H2, 10% CO2) at 37°C. For all experiments, bacteria were grown 
either in control or CSE conditioned media, and bacterial cells were harvested at mid to 
late log phase (P. gingivalis- O.D.600 nm =1.0, corresponding to 10⁹ cells per ml) 
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Identification of essential genes for P. gingivalis survival in GAM-CSE: 
a) Library passage in GAM and GAM-CSE: 
P. gingivalis ATCC 33277 Tnseq mutant library aliquots described in chapter 3  were 
grown in GAM (Control), and GAM-CSE containing 5 µg/ml erythromycin and 50 µg/ml 
gentamycin, as P. gingivalis is naturally resistant to gentamycin and the transposon 
system that is used to create mutant library has erythromycin resistance. After the cultures 
reached mid-late log phase, cultures were passaged twice in GAM and GAM-CSE.  
b) Preparation of DNA for TnSeq analysis: 
Genomic DNA was isolated using Wizard DNA isolation kit and purified using Wizard 
purification kit, as per the manufacturer’s instructions. DNA yields were quantified using a 
NanoDrop ND-1000 spectrophotometer. After DNA isolation, 2 different double-stranded 
DNA (dsDNA) adapter molecules were created, by using primers LIB_AdaptT_3 and 
LIB_AdaptB_3 for CSE model and LIB_AdaptT_4 and LIB_AdaptB_4 for control (Table 
7). The primers were combined and heated at 95°C for 5 min in a water bath and then 
allowed to cool to room temperature. Then, they were aliquoted and stored at -20°C. The 
genomic DNA obtained from the previous step was set for digestion with a Mme1 
restriction enzyme for 1 hour at 37°C followed by for 20 min at 80°C. Then, the obtained 
reactions were purified using Wizard purification kit. This purified digested DNA was then 
run on 1% agarose gel and the band corresponding to approximately 1500 bp (as it 
corresponds to the additive length of both transposon and the flanking sequences) was 
extracted using Wizard gel extraction kit. This Mme1 digested DNA was then ligated to 
barcoded adapter molecules created using T4 DNA ligase incubated for 16 h at 16°C 
followed by heat inactivation for 10 min at 65°C and purified using Wizard purification kit. 
This ligated purified product further amplified by performing PCR using HiFi Hotstart 
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SuperMix with LIB_PCR_5 and LIB_PCR_3 primers (Table 7) using the following PCR 
cycle : 98°C for 3 min, 98°C for 20 sec,60°C for 1 min,72°C for 1 min for 18x cycles and 
72°C for 4 min. The obtained PCR product was purified using Wizard purification kit and 
to verify the 125 bp band Lonza flash gel system was used. Further, the obtained samples 
were quantified using NanoDrop ND-1000 spectrophotometer. Samples were sent to the 
University of Michigan for sequencing using massively parallel sequencing technology, 
Illumina HiSeq2000 platform for quantitative assessment of individual mutants in the 
library by sequencing the transposon-genomic junction.  
c) TnSeq Data Analysis: 
CLC Bioinformatics Workbench 5.5.1 software was used to analyze the TnSeq results. In 
the first step, reads having a quality score <0.05 or of <15 nucleotides were discarded. 
The negative selection method was employed in order to identify the conditional essential 
genes in P. gingivalis. The remaining reads were aligned to the annotated whole genome 
of P. gingivalis ATCC 33277 strain. In each library, 8-14 million reads were identified with 
,on average, 3900 – 6900 genes/read with 52-81% of genes having at least one hit. A total 
of 258 conditional essential genes in GAM-CSE model were identified using the criteria of 
>50 fold change, p<0.01. DAVID database (david.niaid.nih.gov) and KEGG 
(www.genome.jp/kegg) in silico analyses were used to identify the functions and 
interrelationships of these identified conditional essential genes. 
e) Construction of bacterial strains and plasmids: 
P. gingivalis PGN_0388 deletion mutant was generated by homologous recombination, as 
previously described [348]. In brief, two 1-kb flanking regions on either side of the 
PGN_0388 were amplified from genomic DNA by PCR with primer pairs UF, UR and DF 
and DR as shown in Table 12. The PCR product was cloned into plasmid pUC19 with an 
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inserted erythromycin-resistance (erm) cassette (ermF-ermAM) from p1403CeB-H. 
Correct placement and orientation of the DNA segments in the resulting pHBG3 plasmid 
were confirmed by sequencing. The resulting suicide plasmid pHBG3 was electroporated 
into electrocompetent P. gingivalis ATCC 33277 cells for generating the PGN_0388 
mutant, as previously described [349]. Resultant clones were selected on erythromycin 
plates, and double-crossover genomic recombination was confirmed by DNA sequencing 
of the manipulated region.  
 
Figure 5: The pHBG3 plasmid having ori- the origin of replication, bla – beta 
lactamase gene, ermAm-ermF – erythromycin gene cassette and PGN_0388 gene 
flanking regions. 
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f) Competition Assays  
To confirm that the selected mutant strains are specifically outcompeted by the wild-type 
strain in GAM-CSE, competition assays were carried out in in vitro. P. gingivalis ATCC 
33277 and mutant strains were co-cultured in 1:1 ratio in triplicates for two passages in 
GAM, followed by one passage in GAM-CSE having 1000 ng/ml nicotine equivalent. When 
the O.D.600 of cultures reached mid-late log phase, the GAM-CSE culture was plated on 
GAM-blood agar plates with or without antibiotic (5 µg/ml of erythromycin and 5 µg/ml of 
tetracycline for PGN_1200 and PGN_1444). The GAM-CSE culture was spread on the 
plates in triplicate and placed in the anaerobic chamber. After incubation for seven days, 
colony forming units (CFU) were determined. The ratio of the CFU on GAM-blood agar 
plates with or without antibiotics was determined. The mutant strain was considered as 
outcompeted by the wild-type if ≥ 2:1 ratio between wild-type and the mutant strain was 
observed. 
4.3. Results 
The complete database of 258 identified conditional essential genes (50+ fold change, 
p<0.01), in GAM-CSE is provided in Table 10. The identified genes represent 
approximately 8% of the P. gingivalis ATCC 33277 genome and are presented in Figure 
6 using the CGViewer software. KEGG analysis (www.genome.jp/kegg) was employed to 
functionally classify the identified gene set, as noted in Table 9. Out of 258 identified 
essential genes, 22 were annotated as metabolic; 1 as mismatch repair; 1 as aminoacyl-
tRNA biosynthesis; and two as ABC transporters. The metabolic-annotated genes are 
related to pyrimidine metabolism, nicotinate and nicotinamide metabolism, purine 
metabolism, pentose phosphate metabolism, nitrogen metabolism, seleno-compound 
metabolism, alanine aspartate and glutamate metabolism, cysteine, and methionine 
metabolism. Similar functional groupings were obtained using the DAVID database 
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(https://david.ncifcrf.gov/). Functional relationships between the identified conditional 
essential genes were determined using KEGG analysis as shown in Figures 7a-h.  
To validate the Tn-seq results, we are interested in looking at the top genes according to 
fold change, and also the genes of biological significance. PGN_ 0407 (hypothetical gene), 
PGN_ 0025 (spoU;rRNA methylase family protein), PGN_1494 (Oxygen-independent 
coporphyrinogen III oxidase), PGN_ 0388 (Thiol peroxidase), PGN_0604 (Ferritin) are the 
top hits according to the fold change. We were able to generate the PGN_0388 mutant 
using site-directed mutagenesis. The other genes of biological significance are PGN_1524 
encoding tyrosine kinase, PGN_1474 (luxS) encoding S-ribosyl homocysteine lyase, 
PGN_1200 encoding putative ATPase,PGN_1444 (carA) encoding carbamoyl-phosphate 
synthase small chain, PGN_0770 (rnz) encoding ribonuclease Z, PGN_0714 encoding 
probable pyrazinamidase/ nicotinamidase, PGN_0491 encoding probable 
phosphotyrosine protein phosphatase, PGN_0287 (mfa1) encoding minor fimbrium 
subunit Mfa1 , PGN_0088 encoding putative transcriptional regulator. These genes have 
a fold change of >400 in GAM-CSE model except for PGN_1444 and PGN_0770, which 
have a fold change of 172 and 108 respectively. In the competition assays, all the mutants 
except PGN_1444 were outcompeted by the wild type P. gingivalis ATCC 33277 strain. 







Figure 6: Gene map depicting genes essential for the survival of P. gingivalis 
ATCC in GAM-CSE model (Gifu anaerobic medium conditioned with cigarette 
smoke extract). Essential genes were mapped to P. gingivalis ATCC 33277 
genome using CG Viewer. The blue arrows show the location of the 257 essential 
genes in GAM-CSE model within the P. gingivalis 33277 chromosome. The 
adjacent two rings depict gene orientation( outer and inner blue arrows represent 
the positive and negative strands, respectively). The next two rings (red and 
green) represent the blast hits in relation to P. gingivalis TDC60 and W 83 strains, 
respectively. 
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Carbohydrate Metabolism 9/86 (10%) 
Nitrogen Metabolism 1/5 (20%) 
Pyrimidine Metabolism 5/30 (16%) 
Purine Metabolism 2/35 (5%) 
Amino Acid Metabolism 9/74 (12%) 
Nicotinate and Nicotinamide Metabolism  5/13 (38%) 
Thiamine Metabolism  1/7 (14%) 
Porphyrin Metabolism 2/30 (6%) 
Folate Biosynthesis  1/9 (11%) 
Aminoacyl tRNA Biosynthesis  1/4 (12%) 
Mismatch Repair  1/9 (11%) 
Signal Transduction  2/9 (22%) 
Aminobenzoate Degradation  1/2 (50%) 
 
Table 9: Functional classification of conditionally essential genes of P. gingivalis 
in GAM-CSE based on KEGG analysis. 
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Figure 7a: Pyrimidine Metabolism (pathway enriched among conditional essential 
P. gingivalis genes in GAM-CSE). KEGG pathways (www.genome.jp/kegg) are 
presented with the proteins catalyzing each step shown by their enzyme 
commission number and substrates/products. Green shading indicates the 
presence of homologs in P. gingivalis. The red star denotes essential genes. The 




Figure 7b: Purine Metabolism (pathway enriched among conditional essential P. 
gingivalis genes in GAM-CSE). KEGG pathways (www.genome.jp/kegg) are 
presented with the proteins catalyzing each step shown by their enzyme 
commission number and substrates/products. Green shading indicates the 
presence of homologs in P. gingivalis. The red star denotes essential genes. The 







Figure 7c: Nicotinate and Nicotinamide Metabolism (pathway enriched among 
conditional essential P. gingivalis genes in GAM-CSE). KEGG pathways 
(www.genome.jp/kegg) are presented with the proteins catalyzing each step 
shown by their enzyme commission number and substrates/products. Green 
shading indicates the presence of homologs in P. gingivalis. The red star denotes 
essential genes. The PGN assignments of the essential metabolic genes are 







Figure 7d: Mismatch Repair (pathway enriched among conditional essential P. 
gingivalis genes in GAM-CSE). KEGG pathways (www.genome.jp/kegg) are 
presented with the proteins catalyzing each step shown by their enzyme 
commission number and substrates/products. Green shading indicates the 
presence of homologs in P. gingivalis. The red star denotes essential genes. The 




Figure 7e: Aminoacyl tRNA Biosynthesis (pathway enriched among conditional 
essential P. gingivalis genes in GAM-CSE). KEGG pathways 
(www.genome.jp/kegg) are presented with the proteins catalyzing each step 
shown by their enzyme commission number and substrates/products. Green 
shading indicates the presence of homologs in P. gingivalis. The red star denotes 
essential genes. The PGN assignments of the essential metabolic genes are 






Figure 7f: Nitrogen Metabolism (pathway enriched among conditional essential P. 
gingivalis genes in GAM-CSE). KEGG pathways (www.genome.jp/kegg) are 
presented with the proteins catalyzing each step shown by their enzyme 
commission number and substrates/products. Green shading indicates the 
presence of homologs in P. gingivalis. The red star denotes essential genes. The 







Figure 7g: Selenocompound Metabolism (pathway enriched among conditional 
essential P. gingivalis genes in GAM-CSE). KEGG pathways 
(www.genome.jp/kegg) are presented with the proteins catalyzing each step 
shown by their enzyme commission number and substrates/products. Green 
shading indicates the presence of homologs in P. gingivalis. The red star denotes 
essential genes. The PGN assignments of the essential metabolic genes are 









Figure 7h: Alanine, Aspartate and Glutamate Metabolism (pathway enriched 
among conditional essential P. gingivalis genes in GAM-CSE). KEGG pathways 
(www.genome.jp/kegg) are presented with the proteins catalyzing each step 
shown by their enzyme commission number and substrates/products. Green 
shading indicates the presence of homologs in P. gingivalis. The red star denotes 
essential genes. The PGN assignments of the essential metabolic genes are 



































Purine metabolism 1 PGN_1412 
Pentose phosphate metabolism 1 PGN_1941 
Nitrogen metabolism 1 PGN_1746 
Seleno-compound metabolism 1 PGN_1618 










Mismatch repair 1 PGN_1581 
Aminoacyl-tRNA biosynthesis 1 PGN_1646 
ABC transporters 2 PGN_0707 
PGN_0857 
           


























4.4. Discussion  
P. gingivalis, a Gram-negative periodontal pathogen, must overcome the environmental 
stress in the periodontal pocket for its survival and growth. Bacterial adaptation to 
environmental cues involves elaborate regulation of several mechanisms [124]. We were 
interested in identifying conditionally essential genes for P. gingivalis survival in GAM-
CSE, using the generated P. gingivalis ATCC 33277 Tn-seq library. We identified 258 
essential genes for P. gingivalis survival in GAM-CSE. These identified genes account for 
8% of genes in P. gingivalis ATCC 33277 genome.  
PGN_0714 encodes a protein, probable pyrazinamidase/nicotinamidase, involved in the 
nicotinate and nicotinamide metabolism – redox reaction, thus protecting the bacteria from 
the oxidative stress induced by cigarette smoke. PGN_1524 encodes a tyrosine kinase 
which is required for secretion of extracellular polysaccharide and biofilm formation with 
S. gordonii [350].  Bacterial kinases have also been shown to be involved in stress 
responses, antibiotic resistance, and DNA metabolism [351-353]. PGN_0088 (sinR), 
encodes putative transcriptional regulator sinR involved in sequence-specific DNA 
binding. sinR ortholog PGN_0088 inhibits polysaccharide synthesis and affects the 
structure of EPS in P. gingivalis ATCC 33277 biofilms [354]. Further, sinR mutation 
resulted in increased production of exopolysaccharide, leading to increased resistance to 
physical disruption [354]. PGN_1444 encodes a protein involved in pyrimidine biosynthetic 
pathway and glutamine and arginine metabolic processes. PGN_1200 encodes a protein 
involved in DNA replication and repair. PGN_0491 (Ltp1)  encodes phosphotyrosine 
protein phosphatase probable phosphotyrosine protein phosphatase, which regulates the 
expression of luxS and exopolysaccharide synthesis, which play a significant role in biofilm 
formation[355]. PGN_0287 (mfa1), encodes minor fimbrium subunit mfa1. mfa1 is 
involved in bacterial attachment to the host cell surface and other bacteria. Thus, mfa1 
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mediates biofilm formation [356-358]. The competition assay results of the genes 
described so far provide insight into the gene fitness of genes of interest in the GAM-CSE 
model, to promote P. gingivalis growth in media conditioned with cigarette smoke, which 
may have relevance in infection and colonization in vivo. 
Also in the GAM-CSE model, genes involved in carbohydrate and amino acid metabolism; 
ABC transporters were identified as essential genes. The major habitat of P. gingivalis is 
the subgingival sulcus in the oral cavity. It relies on the fermentation of amino acids for 
energy production when sugar availability is low [359]. Also, P. gingivalis serves as a 
secondary colonizer of dental plaque, often adhering to primary colonizers such as S. 
gordonii and Prevotella intermedia. ABC transporter genes are believed to provide 
resistance to P. gingivalis from potentially harmful chemicals in cigarette smoke [180]. 
Several genes encoding nucleotide, energy, cofactors and vitamin metabolism; 
translation, replication, and repair were also identified as essential genes in GAM-CSE 
model. Replication and repair genes protect bacteria from damage as a result of the 
oxidative stress induced by cigarette smoke.  
Future studies using site-directed mutagenesis of top genes according to fold change in 
the GAM-CSE model, and complementation assays of the mutants, can be done to 
further confirm and identify the genes unique to GAM-CSE model. Data generated would 
provide  a better understanding of specific genes, as well as developing novel variants of 
genes of interest. In summary, despite reduced clinical inflammation, smokers are more 
prone to bacterial infection and to develop periodontitis. Our experimental results 
identified several genes essential for P. gingivalis growth and survival when exposed to 
cigarette smoke. Similar analyses can be carried out in other P. gingivalis strains, which 
in turn may provide insight into the common strategies among many bacteria. Apart from 
smoking, the TnSeq library can be tested under other conditions relevant to periodontal 
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diseases, including abscess, biofilm, and TIGK invasion models. In the long-term similar 
analyses, under different conditions and on other bacterial pathogens, to distinguish 
between inherently essential and conditionally essential genes, may reveal additional 




















Periodontal diseases are multifactorial. In this study, we focused on the relationship 
between gestational diabetes mellitus and oral infection with periodontopathogens, and 
the influence of each on systemic inflammation in pregnant women. Also, we focused on 
identification of P. gingivalis ATCC 33277 inherently essential genes and conditional 
essential genes in media conditioned with cigarette smoke.  
Gestational diabetes mellitus is a significant risk factor for periodontal diseases. 
Pregnancy gingivitis is associated with a hormonal imbalance in the pregnant women. As 
stated earlier, in this study we are interested in the microbiological aspect of gingivitis in 
pregnant women. It has been found that the gingivitis during pregnancy was associated 
with the increased oral infection with P. gingivalis, F. alocis, and T. denticola and 
combinations of the three. Gestational diabetes mellitus was also associated with 
increased infection with individual and multiple periodontopathogens. An interesting 
finding observed in our study is that it is the gingivitis, rather than GDM, that is the driving 
force for the increased systemic inflammation in pregnant women. 
We successfully generated a P. gingivalis ATCC 33277 transposon library covering a wide 
range of the genome which enabled us to identify the inherently essential genes in P. 
gingivalis ATCC 33277 strain. Further, we compared the generated library with the existing 
library (Klein et al., 2012) in order to identify the common inherently essential genes. We 
entered the identified inherently essential genes in DEG database, which has only 36 
bacterial essential genes apart from P. gingivalis. As the database grows, we can compare 
the obtained inherently essential gene list to essential gene list of other bacteria. This 
comparison, in turn, will help us to identify the species specific essential genes and also 
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essential genes common in many bacterial species. These identified genes might serve 
as new therapeutic targets to combat P. gingivalis specific infection or to control several 
infections at the same time. Further, the P. gingivalis ATCC 33277 transposon library can 
be tested under variable conditions such as cigarette smoke, invasion model and mouse 
models to identify the conditional essential genes. 
Cigarette smoke is an important environmental modifiable risk factor for periodontal 
diseases. Despite reduced clinical signs of periodontal inflammation in smokers, cigarette 
smoke is known to increase periodontal pathogen infection. The exact reason for the 
increased periodontal pathogen infection is unclear. For periodontal pathogens, such 
as P. gingivalis to induce or exacerbate periodontal diseases in smokers, they must first 
be able to survive the highly complex composite toxic insult represented by cigarette 
smoke. While P. gingivalis is resistant to very high doses of cigarette smoke and tobacco 
constituents, the survival mechanisms are entirely unknown. We identified conditional 
essential genes for P. gingivalis survival in GAM-CSE, which are involved in several 
metabolic pathways, which enable P. gingivalis to combat the stress induced by cigarette 
smoke. Apart from the genes involved in metabolic processes, several genes involved in 
P. gingivalis attachment to host tissues and other bacterial species were also identified in 
GAM-CSE model. The genes identified so far are from several studies that have shown 
increased homotypic and heterotypic biofilm formation by P. gingivalis under the influence 
of cigarette smoke [157, 197, 360]. These findings support the idea of increased 
periodontal pathogen infection in smokers as a result of the dysbiotic influence of P. 
gingivalis.  
From the above studies, we can state that oral pathogens drive the systemic inflammation 
in pregnant women and, also that P. gingivalis adapts to environmental cues. It can also 
be inferred that these adaptations are essential to enabling its survival. Further, adaptive 
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mechanisms may also promote bacterial interaction with other oral pathogens, which in 
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